헬스케어의 인공지능(AI) 시장 – 2030년까지의 세계 예측

Artificial Intelligence (AI) In Healthcare Market – Global Forecast To 2030

헬스케어의 인공지능(AI) 시장 – 제공 내용(통합), 기능(진단, 게놈, 정밀 의료, 방사선, 면역요법, 약국, 공급망), 용도(임상), 최종 사용자(병원), 지역별 – 2030년까지의 세계 예측

Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Immunotherapy, Pharmacy, Supply Chain), Application (Clinical), End User (Hospitals), Region – Global Forecast to 2030

　　　　주문/문의　　　　조사회사/라이센스/납기안내

본 보고서는 의료 인공지능(AI) 시장을 분석하고, 제품, 솔루션 유형, 영상 방식, 애플리케이션, 최종 사용자 및 지역을 기준으로 다양한 시장 부문의 시장 규모와 미래 성장 잠재력을 예측합니다. 또한 시장 성장에 영향을 미치는 요인(동인, 기회, 과제 등)을 분석하고, 시장 이해관계자의 기회와 과제를 평가합니다. 또한, 성장 추세, 전망, 그리고 전체 의료 인공지능(AI) 시장에 대한 기여도를 바탕으로 미시 시장(micro market)을 분석합니다. 5개 주요 지역을 기준으로 시장 부문의 매출을 예측합니다. 또한, 이 시장의 주요 업체에 대한 경쟁 분석과 함께 회사 프로필, 제품 제공, 최근 동향, 주요 시장 전략 등을 제공합니다.

The global Artificial Intelligence (AI) in healthcare market is projected to reach USD 110.61 billion by 2030 from USD 21.66 billion in 2025, at a CAGR of 38.6% during the forecast period.

글로벌 헬스케어의 인공지능(AI) 시장은 2025년 216억 6천만 달러에서 2030년 1,106억 1천만 달러로 성장할 것으로 예상되며, 이는 예측 기간 동안 연평균 성장률 38.6%를 기록할 것입니다.

The market is expected to grow due to the growing investments & funding by public-private organizations, the fast proliferation of AI in the healthcare industry, and the rising focus on developing human-aware AI systems. The market has experienced growth due to increasing demand for enhanced services due to an unequal ratio between the healthcare workforce and patient numbers. However, inadequate IT infrastructure and unwillingness to adopt AI-based healthcare solutions in emerging economies are estimated to pose a challenge to market growth.

공공-민간 기관의 투자 및 자금 지원 증가, 의료 산업에서 AI의 빠른 확산, 그리고 인간 인지 AI 시스템 개발에 대한 관심 증가로 인해 시장 성장이 예상됩니다. 의료 인력과 환자 수의 불균형으로 인한 향상된 서비스에 대한 수요 증가로 시장이 성장해 왔습니다. 그러나 신흥 경제권의 IT 인프라 부족과 AI 기반 의료 솔루션 도입에 대한 의지 부족은 시장 성장에 걸림돌이 될 것으로 예상됩니다.

By deployment, the cloud-based segment is expected to register the highest growth during the forecast period.

The AI in healthcare market is categorized into three deployment models: on-premise, cloud-based, and hybrid models. The cloud-based models segment holds the largest share due to the scalability, cost-effectiveness, and accessibility of these models. Cloud-based models facilitate real-time data processing and collaboration. They allow for seamless integration, secure data storage, and rapid deployment, making them particularly suitable for healthcare providers and payers. They provide faster, more reliable care while maintaining high-quality standards. Cloud-based AI solutions are becoming increasingly popular due to their cost-effectiveness, scalability, and support for remote access. These solutions enable seamless integration and real-time analytics. The growing adoption of telehealth and advancements in healthcare IT infrastructure further drive the demand for cloud-based models.

By end user, the hospitals & clinics segment dominated the market in the Artificial Intelligence (AI) in healthcare market for healthcare providers in 2024.

By end user, Artificial Intelligence (AI) in healthcare market is segmented into hospitals & clinics, ambulatory surgical centers, home healthcare agencies & assisted living facilities, diagnostic & imaging centers, pharmacies, and other healthcare providers. The hospitals & clinics segment accounted for the largest share of the Artificial Intelligence (AI) in healthcare market. This is attributed to the increasing demand for personalized medicines, precise diagnostics & surgical planning, growth in minimally-invasive procedures, and the requirement for interoperability with existing systems. AI-based healthcare solutions enhance diagnostic accuracy, streamline operations, and personalize care in hospitals and clinics. They automate administrative tasks, predict patient outcomes, and enable faster decision-making with real-time data analysis. AI also supports remote monitoring, optimizes resources, and reduces costs by minimizing unnecessary treatments. AI improves patient engagement through virtual assistants and enhances security by detecting fraud, making healthcare more efficient, accessible, and cost-effective.

Asia Pacific is expected to register the highest growth during the forecast period.

The Artificial Intelligence (AI) in healthcare market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is expected to register the highest growth during the forecast period. The Asia Pacific (APAC) region is experiencing substantial growth in the adoption of AI technologies within the healthcare sector, driven by a combination of demographic shifts, technological advancements, and increased investments in innovation. The rising elderly population in the Asia Pacific is a key factor, with the proportion of individuals aged 65 years and above increasing significantly. According to the UN’s World Population Aging 2020 report, the global population in this age group is expected to double from 727 million in 2020 to 1.5 billion by 2050, with Eastern and Southeastern Asia contributing a large share of this growth.

The break-down of primary participants is as mentioned below:

• By Company Type – Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
• By Designation – Directors: 30%, Manager: 34%, and Others: 36%
• By Region – North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7% and Middle East & Africa: 5%

Key Players

The prominent players operating in the Artificial Intelligence (AI) in healthcare market include Koninklijke Philips N.V. (Netherlands), Microsoft Corporation  (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US), GE Healthcare (US), Medtronic (US), Oracle (US), Veradigm LLC  (US), Merative (IBM) (US), Google (US), Cognizant (US), Johnson & Johnson (US), Amazon Web Services, Inc. (US), SOPHiA GENETICS (US), Riverian Technologies (US), Terarecon (ConcertAI) (US), Solventum Corporation (US), Tempus (US), Viz.ai (US). These companies adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, mergers, and acquisitions to strengthen their market presence in the Artificial Intelligence (AI) in healthcare market.

Research Coverage

The report analyzes the Artificial Intelligence (AI) in healthcare market and aims to estimate the market size and future growth potential of various market segments based on offering, solution type, imaging modality, application, end user, and region. The report also analyzes factors (such as drivers, opportunities, and challenges) affecting market growth. It evaluates the opportunities and challenges in the market stakeholders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total Artificial Intelligence (AI) in healthcare market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a higher market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of key drivers (exponential growth in data volume and complexity due to surging adoption of digital technologies, significant cost pressure on healthcare service providers with increasing prevalence of chronic diseases, rapid proliferation of AI in healthcare sector, growing need for improvised healthcare services, growing need for early detection and diagnosis, restraints (reluctance among medical practitioners to adopt AI-based technologies, shortage of skilled AI professionals handling AI-powered solutions, lack of standardized frameworks for AI and ML technologies), opportunities (increasing use of AI-powered solutions in elderly care, increasing focus on developing human-aware AI systems, strategic partnerships and collaborations among healthcare companies and AI technology providers), challenges (inaccurate predictions due to scarcity of high-quality healthcare data, concerns regarding data privacy, lack of interoperability between AI solutions offered by different vendors) are factors contributing the growth of the Artificial Intelligence (AI) in healthcare market
• Product Development/Innovation: Detailed insights into upcoming trends, research & development activities, and software launches in the Artificial Intelligence (AI) in healthcare market
• Market Development: Comprehensive information on the lucrative emerging markets, type of solution, component, deployment model, industry, and region
• Market Diversification: Exhaustive information about software portfolios, growing geographies, recent developments, and investments in the Artificial Intelligence (AI) in healthcare market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Artificial Intelligence (AI) in healthcare market, such as Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US)

Table of Contents

1               INTRODUCTION              58

1.1           STUDY OBJECTIVES       58

1.2           MARKET DEFINITION   58

1.3           STUDY SCOPE   59

1.3.1        MARKETS COVERED       59

1.3.2        INCLUSIONS & EXCLUSIONS       60

1.3.3        YEARS CONSIDERED      63

1.4           CURRENCY CONSIDERED            64

1.5           STAKEHOLDERS               64

2               RESEARCH METHODOLOGY       65

2.1           RESEARCH DATA              65

2.1.1        SECONDARY DATA          66

2.1.1.1    Key data from secondary sources       67

2.1.2        PRIMARY DATA 67

2.1.2.1    Key industry insights           69

2.2           MARKET SIZE ESTIMATION         70

2.3           DATA TRIANGULATION                76

2.4           MARKET SHARE ESTIMATION    77

2.5           STUDY ASSUMPTIONS  77

2.6           LIMITATIONS    77

2.6.1        METHODOLOGY-RELATED LIMITATIONS           77

2.6.2        SCOPE-RELATED LIMITATIONS                 77

2.7           RISK ASSESSMENT           78

3               EXECUTIVE SUMMARY  79

4               PREMIUM INSIGHTS       85

4.1           AI IN HEALTHCARE MARKET OVERVIEW               85

4.2           ASIA PACIFIC: AI IN HEALTHCARE, BY OFFERING AND COUNTRY            86

4.3           AI IN HEALTHCARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              87

4.4           AI IN HEALTHCARE MARKET: REGIONAL MIX     87

4.5           AI IN HEALTHCARE: DEVELOPED VS. EMERGING MARKETS             88

5               MARKET OVERVIEW       89

5.1           INTRODUCTION              89

5.2           MARKET DYNAMICS       89

5.2.1        DRIVERS               90

5.2.1.1    Increase in need for early detection and diagnosis          90

5.2.1.2    Exponential growth in data volume and complexity due to surging adoption of digital technologies         91

5.2.1.3    Significant cost pressure on healthcare service providers with increasing prevalence of chronic diseases         91

5.2.1.4    Rapid proliferation of AI in healthcare sector  92

5.2.1.5    Growth in need for improvised healthcare services        93

5.2.2        RESTRAINTS      93

5.2.2.1    Reluctance among medical practitioners to adopt AI-based technologies           93

5.2.2.2    Shortage of skilled AI professionals handling AI-powered solutions 94

5.2.2.3    Lack of standardized frameworks for AI and ML technologies                 94

5.2.3        OPPORTUNITIES              95

5.2.3.1    Increasing use of AI-powered solutions in elderly care  95

5.2.3.2    Increase in focus on developing human-aware AI systems                 95

5.2.3.3    Strategic partnerships and collaborations among healthcare companies and AI technology providers           96

5.2.4        CHALLENGES    97

5.2.4.1    Inaccurate predictions due to scarcity of high-quality healthcare data         97

5.2.4.2    Concerns regarding data privacy        98

5.2.4.3    Lack of interoperability between AI solutions offered by different vendors  99

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       100

5.4           TECHNOLOGY ANALYSIS             101

5.4.1        KEY TECHNOLOGIES     101

5.4.1.1    Machine learning (ML) and deep learning      101

5.4.1.2    Natural language processing (NLP)  101

5.4.1.3    Computer vision (CV)         101

5.4.2        COMPLEMENTARY TECHNOLOGIES       102

5.4.2.1    Cloud computing  102

5.4.2.2    Digital twins          102

5.4.2.3    Robotic process automation (RPA)   102

5.4.3        ADJACENT TECHNOLOGIES       102

5.4.3.1    Blockchain             102

5.4.3.2    Augmented and virtual reality (AR/VR)           103

5.4.3.3    Internet of things (IoT)       103

5.5           INDUSTRY TRENDS         103

5.5.1        SHIFT TOWARD PERSONALIZED MEDICINE        103

5.5.2        AI IN DIAGNOSTICS AND IMAGING         104

5.6           PRICING ANALYSIS          104

5.6.1        INDICATIVE PRICING OF AI IN HEALTHCARE SOFTWARE, BY DEPLOYMENT MODEL (QUALITATIVE) 105

5.6.2        INDICATIVE PRICING OF AI IN HEALTHCARE SOFTWARE, BY REGION (QUALITATIVE)               105

5.7           VALUE CHAIN ANALYSIS               106

5.8           ECOSYSTEM ANALYSIS  107

5.9           PATENT ANALYSIS          110

5.9.1        INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS            110

5.10         KEY CONFERENCES & EVENTS   114

5.11         CASE STUDY ANALYSIS 115

5.11.1      BIOBEAT LAUNCHED HOME-BASED REMOTE PATIENT MONITORING KIT DURING PEAK WAVE OF COVID-19    115

5.11.2      MICROSOFT COLLABORATED WITH CLEVELAND CLINIC TO APPLY PREDICTIVE AND ADVANCED ANALYTICS TO IDENTIFY POTENTIAL AT-RISK PATIENTS UNDER ICU CARE                 116

5.11.3      TGEN COLLABORATED WITH INTEL CORPORATION AND DELL TECHNOLOGIES TO ASSIST PHYSICIANS AND RESEARCHERS IN ACCELERATING DIAGNOSIS AND TREATMENT AT LOWER COSTS                116

5.11.4      GE HEALTHCARE IMPROVED PATIENT OUTCOMES BY REDUCING WORKFLOW PROCESSING TIME USING MEDICAL IMAGING DATA                 117

5.12         REGULATORY LANDSCAPE         117

5.12.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             117

5.12.2      REGULATORY FRAMEWORK       120

5.12.2.1  North America      120

5.12.2.2  Europe   122

5.12.2.3  Asia Pacific            122

5.12.2.4  Middle East & Africa            123

5.12.2.5  Latin America       124

5.13         PORTER’S FIVE FORCES ANALYSIS           124

5.13.1      THREAT OF NEW ENTRANTS      125

5.13.2      THREAT OF SUBSTITUTES          126

5.13.3      BARGAINING POWER OF SUPPLIERS       126

5.13.4      BARGAINING POWER OF BUYERS             126

5.13.5      INTENSITY OF COMPETITIVE RIVALRY 126

5.14         KEY STAKEHOLDERS & BUYING CRITERIA            127

5.14.1      KEY STAKEHOLDERS IN BUYING PROCESS           127

5.14.2      BUYING CRITERIA           128

5.15         END-USER ANALYSIS      129

5.15.1      UNMET NEEDS 129

5.15.2      END-USER EXPECTATIONS         130

5.16         AI IN HEALTHCARE BUSINESS MODELS 131

5.16.1      SOFTWARE-AS-A-SERVICE (SAAS) MODEL            131

5.16.2      LICENSING MODEL         131

5.16.3      REVENUE SHARING/OUTCOME-BASED MODEL 131

5.16.4      FREEMIUM MODEL         131

5.16.5      AI-AS-A-SERVICE (AIAAS) MODEL             131

5.16.6      PARTNERSHIP/REVENUE-SHARING MODEL        132

5.16.7      HYBRID MODELS             132

5.16.8      PAY-PER-USE MODELS  132

5.17         INVESTMENT & FUNDING SCENARIO     132

5.18         IMPACT OF GENERATIVE AI ON AI IN HEALTHCARE MARKET               133

5.18.1      INTRODUCTION              133

5.18.2      MARKET POTENTIAL OF GEN AI IN HEALTHCARE                 133

5.18.2.1  Key use cases of Gen AI      134

5.18.3      CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION         135

5.18.3.1  Eka Care leveraging generative AI for improved health outcomes                 135

5.18.4      INTERCONNECTED AND ADJACENT ECOSYSTEMS                 136

5.18.4.1  AI in healthcare IT               137

5.18.4.2  AI in medical diagnostics    137

5.18.4.3  AI in oncology       138

5.18.4.4  AI in clinical trials 138

5.18.4.5  AI in drug discovery             138

5.18.5      USER READINESS & IMPACT ASSESSMENT            139

5.18.5.1  User readiness       139

5.18.5.1.1                Healthcare providers            139

5.18.5.1.2                Healthcare payers 139

5.18.5.1.3                Patients  139

5.18.5.2  Impact assessment                140

5.18.5.2.1                User A: Healthcare providers              140

5.18.5.2.1.1            Implementation    140

5.18.5.2.1.2            Impact    140

5.18.5.2.2                User B: Healthcare payers  140

5.18.5.2.2.1            Implementation    140

5.18.5.2.2.2            Impact    141

5.18.5.2.3                User C: Patients   141

5.18.5.2.3.1            Implementation    141

5.18.5.2.3.2            Impact    141

6               IMPACT OF 2025 US TARIFF – OVERVIEW              142

6.1           INTRODUCTION              142

6.2           KEY TARIFF RATES          142

6.3           PRICE IMPACT ANALYSIS             143

6.4           IMPACT ON COUNTRY/REGION                144

6.4.1        US           144

6.4.2        EUROPE               145

6.4.3        ASIA PACIFIC     145

6.5           IMPACT ON END-USE INDUSTRIES          146

7               AI IN HEALTHCARE MARKET, BY OFFERING        147

7.1           INTRODUCTION              148

7.2           INTEGRATED SOLUTIONS           148

7.2.1        RISE IN WORKFORCE CHALLENGES AND COST PRESSURES TO DRIVE ADOPTION            148

7.3           NICHE/POINT SOLUTIONS          149

7.3.1        TARGETED AI SOLUTIONS TRANSFORMING PRECISION CARE AND EFFICIENCY IN HEALTHCARE TO BOOST MARKET                 149

7.4           AI TECHNOLOGIES         150

7.4.1        ABILITY OF CORE AI TECHNOLOGIES TO DRIVE PRECISION, EFFICIENCY, AND INNOVATION TO SUPPORT MARKET GROWTH          150

7.5           SERVICES             151

7.5.1        NEED TO EMPOWER NON-CLINICAL HEALTHCARE OPERATIONS TO FUEL MARKET GROWTH           151

8               AI IN HEALTHCARE MARKET, BY FUNCTION       153

8.1           INTRODUCTION              154

8.2           DIAGNOSIS & EARLY DETECTION            154

8.2.1        PRE-SCREENING               156

8.2.1.1    Early detection, better outcomes, and cost-effective care associated with pre-screening to boost market                 156

8.2.2        IVD         156

8.2.2.1    IVD market, by technology 157

8.2.2.1.1 Immunoassays      158

8.2.2.1.1.1              Increase in focus on earlier disease detection & personalized treatment planning to drive market            158

8.2.2.1.2 Clinical chemistry 158

8.2.2.1.2.1              Increased demand for precision and personalized medicine and efficient healthcare systems to drive market            158

8.2.2.1.3 Molecular diagnostics          159

8.2.2.1.3.1              Improved disease detection, personalized treatments, and enhanced outcomes to fuel growth             159

8.2.2.2    IVD market, by application 160

8.2.2.2.1 Image analysis & interpretation          160

8.2.2.2.1.1              Advantages such as enhanced diagnostic accuracy, faster detection, and improved patient outcomes to support growth                 160

8.2.2.2.2 Biomarker discovery & analysis          161

8.2.2.2.2.1              Ability of AI-based biomarker discovery to enhance disease detection, prognosis, and personalized treatment to drive adoption                 161

8.2.2.2.3 Other IVD applications       162

8.2.3        DIAGNOSTIC IMAGING 162

8.2.3.1    Diagnostic imaging market, by application      163

8.2.3.1.1 Disease interpretation & report analysis           164

8.2.3.1.1.1              Ability of AI-driven disease interpretation to accelerate diagnosis, treatment, and outcomes to fuel growth         164

8.2.3.1.2 Image captioning & annotation          164

8.2.3.1.2.1              Enhanced diagnostic accuracy, efficiency, and consistency associated with image captioning & annotation to boost market    164

8.2.3.1.3 Image reconstruction           165

8.2.3.1.3.1              Improved diagnostic precision, efficiency, and image quality in healthcare to drive market 165

8.2.3.1.4 Other diagnostic imaging applications              166

8.2.3.2    Diagnostic imaging market, by modality          166

8.2.3.2.1 Magnetic resonance imaging (MRI) 167

8.2.3.2.1.1              Rise in technological advancements to drive adoption of AI in MRI               167

8.2.3.2.2 Computed tomography (CT)              168

8.2.3.2.2.1              Increase in availability of cardiac CT devices enabled with AI solutions to drive market       168

8.2.3.2.3 X-ray imaging        169

8.2.3.2.3.1              Innovative AI solutions for X-ray imaging by key players to drive market      169

8.2.3.2.4 Ultrasound             170

8.2.3.2.4.1              Increase in prevalence of and need for early detection of ovarian cancer to drive market           170

8.2.3.2.5 Nuclear imaging (PET & SPECT)    171

8.2.3.2.5.1              Critical role played by PET and SPECT in visualizing metabolic processes to contribute to growth    171

8.2.3.2.6 Other diagnostic imaging modalities 171

8.2.4        RISK ASSESSMENT & PATIENT STRATIFICATION                 172

8.2.4.1    AI-driven risk assessment and patient stratification to enhance healthcare efficiency, outcomes, and personalized care 172

8.2.5        DRUG ALLERGY ALERTING         173

8.2.5.1    Ability of AI-enhanced drug allergy alerting to improve accuracy and patient safety to boost market     173

8.2.6        OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS                 174

8.3           TREATMENT PLANNING & PERSONALIZATION 175

8.3.1        PERSONALIZED TREATMENT PLANNING             176

8.3.1.1    Precision medicine & genomic analysis            177

8.3.1.1.1 Advantages such as accurate disease predictions and improved outcomes to drive demand  177

8.3.1.2    Predictive models for treatment response        178

8.3.1.2.1 Ability to personalize therapies, improve outcomes, and minimize adverse effects to fuel growth             178

8.3.1.3    Treatment recommendation systems                179

8.3.1.3.1 Optimized healthcare delivery associated with treatment recommendation systems to support growth   179

8.3.2        PHARMACOLOGICAL THERAPY                 180

8.3.2.1    Drug response prediction   181

8.3.2.1.1 Growth in use of drug response prediction to minimize adverse reactions to drive segment  181

8.3.2.2    Dosing & administration     181

8.3.2.2.1 Improved efficacy with highly personalized administration care to fuel adoption         181

8.3.2.3    Other pharmacological therapy functions        182

8.3.3        SURGICAL THERAPY       183

8.3.3.1    Preoperative imaging & 3D modeling               184

8.3.3.1.1 Enhanced surgical planning and precision to propel market                 184

8.3.3.2    Intraoperative guidance & robotics   184

8.3.3.2.1 Faster recovery time post surgery to boost adoption      184

8.3.3.3    Postoperative analysis & recovery      185

8.3.3.3.1 Reduced complications with real-time monitoring to drive market                 185

8.3.4        RADIATION THERAPY   186

8.3.4.1    Motion synchronization & auto contouring     187

8.3.4.1.1 Optimized radiation therapy with motion synchronization & auto contouring to boost market 187

8.3.4.2    Real-time adaptive treatment delivery               188

8.3.4.2.1 Reduced side effects with effective adaptive treatment to propel demand  188

8.3.4.3    Response assessment & quality assurance        188

8.3.4.3.1 Ability of AI to enhance response assessment and QA to spur growth    188

8.3.4.4    Other radiation therapy functions     189

8.3.5        BEHAVIORAL THERAPY & PSYCHOTHERAPY       190

8.3.5.1    Virtual counseling & chatbots             191

8.3.5.1.1 Ability to engage patients remotely to drive market demand                 191

8.3.5.2    Progress monitoring & feedback        191

8.3.5.2.1 Increasing use of smart wearables and mobile health apps to drive market    191

8.3.5.3    Follow-up & long-term support         192

8.3.5.3.1 Widespread adoption of telemedicine platforms to drive market demand  192

8.3.6        IMMUNOTHERAPY          193

8.3.6.1    Real-time patient data monitoring     194

8.3.6.1.1 Need for real-time data analysis to make informed decisions to boost market growth             194

8.3.6.2    Response & side-effect prediction     195

8.3.6.2.1 Ability to reduce trial-and-error approach in medical treatments to drive segmental growth   195

8.3.6.3    Relapse prediction & long-term management 195

8.3.6.3.1 Need for proactive approach for long-term care to fuel market growth    195

8.3.7        OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS       196

8.4           PATIENT ENGAGEMENT & REMOTE MONITORING                 197

8.4.1        SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE                 198

8.4.1.1    Rising prevalence of chronic diseases to drive market growth                 198

8.4.2        TELEHEALTH & REMOTE PATIENT MONITORING                 199

8.4.2.1    Ability to monitor and evaluate patients remotely to boost market demand  199

8.4.3        HEALTHCARE ASSISTANCE ROBOTS       199

8.4.3.1    Advancements in robotics and artificial intelligence (AI) to boost market demand     199

8.4.4        MEDICATION REMINDERS           200

8.4.4.1    Increasing adoption of smartphone applications and IoT devices to surge market demand      200

8.4.5        PATIENT EDUCATION & EMPOWERMENT            201

8.4.5.1    Need to improve treatment adherence and enhance self-management to drive market growth 201

8.4.6        OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS         202

8.5           POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE     203

8.5.1        RECURRENCE MONITORING      204

8.5.1.1    Need to predict recurrence of cancer to drive market    204

8.5.2        LONG-TERM OUTCOME PREDICTION   204

8.5.2.1    Ability to predict long-term health outcomes and enhance patient care to drive market              204

8.5.3        MENTAL HEALTH & SUPPORT SYSTEMS                205

8.5.3.1    Need to help patients cope with mental strain to drive market                 205

8.6           PHARMACY MANAGEMENT        206

8.6.1        EPRESCRIBING 207

8.6.1.1    Need to improve safety and efficiency in prescription to drive market    207

8.6.2        MEDICATION MANAGEMENT    207

8.6.2.1    Ability to predict adverse drug reactions by patient data analysis to drive market      207

8.6.3        PHARMACY AUDIT & ANALYSIS 208

8.6.3.1    Need for effective and efficient operation of pharmacies to drive market    208

8.6.4        OTHER PHARMACY MANAGEMENT FUNCTIONS                 209

8.7           DATA MANAGEMENT & ANALYTICS        210

8.7.1        ABILITY OF DATA MANAGEMENT & ANALYTICS TO HELP HEALTHCARE ORGANIZATIONS MAKE INFORMED DECISIONS TO BOOST MARKET                210

8.8           ADMINISTRATIVE            210

8.8.1        PATIENT REGISTRATION & SCHEDULING            212

8.8.1.1    Need to optimize patient registration process for smoother operations to drive market  212

8.8.2        PATIENT ELIGIBILITY & AUTHORIZATION           213

8.8.2.1    Need to reduce administrative burden to drive market  213

8.8.3        BILLING & CLAIMS MANAGEMENT          214

8.8.3.1    Need to make billing process more accurate, efficient, and transparent to drive market                 214

8.8.4        WORKFORCE MANAGEMENT     215

8.8.4.1    Need for effective staff management to drive market     215

8.8.5        SUPPLY CHAIN & INVENTORY MANAGEMENT   216

8.8.5.1    Ability to make better procurement decisions to fuel market                 216

8.8.6        COMPLIANCE & DOCUMENTATION        217

8.8.6.1    Need to reduce manual paperwork and errors to drive market                 217

8.8.7        HEALTHCARE WORKFLOW MANAGEMENT         218

8.8.7.1    Need to optimize and automate processes within healthcare facilities to drive market      218

8.8.8        ASSET MANAGEMENT   219

8.8.8.1    Ability to optimize use and allocation of resources to drive market                 219

8.8.9        CUSTOMER RELATIONSHIP MANAGEMENT        220

8.8.9.1    Enhancing patient engagement and retention through AI-driven CRM systems to boost market            220

8.8.10      FRAUD DETECTION & RISK MANAGEMENT         221

8.8.10.1  Need to enhance security in healthcare systems to drive market demand  221

8.8.11      CYBERSECURITY              222

8.8.11.1  Enhancing healthcare cybersecurity with AI-driven threat detection and risk management to fuel growth                222

8.8.12      OTHER ADMINISTRATIVE FUNCTIONS 223

9               AI IN HEALTHCARE MARKET, BY APPLICATION 224

9.1           INTRODUCTION              225

9.2           CLINICAL APPLICATIONS            225

9.2.1        ABILITY OF AI TO IMPROVE DIAGNOSTICS, TREATMENT, AND PATIENT CARE TO DRIVE MARKET GROWTH                 225

9.3           NON-CLINICAL APPLICATIONS 227

9.3.1        ABILITY OF AI TO REDUCE ADMINISTRATIVE BURDEN AND ENSURE BETTER RESOURCE ALLOCATION TO FUEL GROWTH             227

10            AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL                 229

10.1         INTRODUCTION              230

10.2         ON-PREMISE MODELS   230

10.2.1      ENHANCED DATA SECURITY AND COMPLIANCE TO PROPEL ADOPTION OF ON-PREMISE AI MODELS             230

10.3         CLOUD-BASED MODELS               231

10.3.1      SCALABILITY AND AUTOMATION OF CLOUD-BASED AI PLATFORMS TO RESHAPE HEALTHCARE DELIVERY GLOBALLY                 231

10.4         HYBRID MODELS             233

10.4.1      FLEXIBILITY FOR DIVERSE APPLICATIONS TO BOOST DEMAND FOR HYBRID MODELS                233

11            ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TOOL              234

11.1         INTRODUCTION              235

11.2         MACHINE LEARNING     235

11.2.1      DEEP LEARNING               237

11.2.1.1  Convolutional neural networks (CNN)             239

11.2.1.1.1                Growing demand for advance medical imaging and diagnostics to drive market growth    239

11.2.1.2  Recurrent neural networks (RNN)    240

11.2.1.2.1                Ability of RNN to enhance predictive analytics in healthcare to boost market  240

11.2.1.3  Generative adversarial networks (GAN)          240

11.2.1.3.1                Ability to transform data scarcity and privacy in AI-driven healthcare to drive demand for GAN    240

11.2.1.4  Graph neural networks (GNN)          241

11.2.1.4.1                Ability of GNN to revolutionize relational insights in healthcare analytics to fuel growth    241

11.2.1.5  Other deep learning tools   242

11.2.2      SUPERVISED LEARNING                242

11.2.2.1  Need to drive precision and efficiency in healthcare to support adoption of supervised learning tools                242

11.2.3      REINFORCEMENT LEARNING     243

11.2.3.1  Wide usage of reinforcement learning models for real-time and adaptive healthcare solutions to support market growth                243

11.2.4      UNSUPERVISED LEARNING         244

11.2.4.1  Ability of unsupervised learning to drive innovation in healthcare analytics to propel market   244

11.2.5      OTHER MACHINE LEARNING TOOLS      245

11.3         NATURAL LANGUAGE PROCESSING (NLP)           246

11.3.1      SENTIMENT ANALYSIS  247

11.3.1.1  Enhanced patient experience and operational insights to spur demand for sentiment analysis           247

11.3.2      PATTERN & IMAGE RECOGNITION          248

11.3.2.1  Increased precision in clinical decision-making associated with pattern & image recognition to aid market       248

11.3.3      AUTO CODING 248

11.3.3.1  Advantages such as improved medical billing and administrative efficiency to boost market   248

11.3.4      CLASSIFICATION & CATEGORIZATION  249

11.3.4.1  Ability of classification & categorization to organize healthcare data for better outcomes to propel market       249

11.3.5      TEXT ANALYTICS             250

11.3.5.1  Ability to transform unstructured data into actionable healthcare insights to fuel growth         250

11.3.6      SPEECH RECOGNITION 250

11.3.6.1  Improved speech recognition advancing real-time documentation and accessibility to drive demand      250

11.4         CONTEXT-AWARE COMPUTING                251

11.4.1      DEVICE CONTEXT           252

11.4.1.1  Real-time monitoring and decision-making to contribute to market growth       252

11.4.2      USER CONTEXT                253

11.4.2.1  Personalized healthcare and adaptive workflows to drive demand                 253

11.4.3      PHYSICAL CONTEXT      254

11.4.3.1  Location-based services associated with physical context to generate demand  254

11.5         GENERATIVE AI                255

11.5.1      ABILITY OF GENERATIVE AI MODELS TO MIMIC DISEASE PROGRESSION TO DRIVE MARKET        255

11.6         COMPUTER VISION        256

11.6.1      ABILITY TO DETECT ABNORMALITIES SUCH AS TUMORS TO FUEL ADOPTION  256

11.7         IMAGE ANALYSIS              257

11.7.1      NEED TO STREAMLINE DOCUMENT MANAGEMENT TO PROPEL MARKET             257

12            AI IN HEALTHCARE MARKET, BY END USER        259

12.1         INTRODUCTION              260

12.2         HEALTHCARE PROVIDERS           260

12.2.1      HOSPITALS & CLINICS   263

12.2.1.1  Growing need to improve profitability of healthcare to drive use of AI-based healthcare solutions in hospitals   263

12.2.2      AMBULATORY CARE CENTERS  264

12.2.2.1  Supportive government norms and incentives for HCIT solutions and services to drive market growth  264

12.2.3      HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES         265

12.2.3.1  Growing need for long-term home care to drive market growth                 265

12.2.4      DIAGNOSTIC & IMAGING CENTERS         266

12.2.4.1  Growing burden of various chronic diseases to propel market growth    266

12.2.5      PHARMACIES     268

12.2.5.1  Advantages of workflow improvements and error reduction to drive AI-based healthcare solution adoption in pharmacies          268

12.2.6      OTHER HEALTHCARE PROVIDERS           269

12.3         HEALTHCARE PAYERS   269

12.3.1      PUBLIC PAYERS                270

12.3.1.1  Focus on developing outcome-based payment models to drive demand for payer solutions 270

12.3.2      PRIVATE PAYERS              271

12.3.2.1  Possible increases in operational efficiency to boost demand among private payers           271

12.4         PATIENTS            272

12.4.1      RISE IN USE OF AI IN MENTAL HEALTH SUPPORT APPLICATIONS THROUGH CHATBOTS AND VIRTUAL THERAPISTS TO BOOST MARKET             272

12.5         OTHER END USERS         273

13            AI IN HEALTHCARE MARKET, BY REGION             275

13.1         INTRODUCTION              276

13.2         NORTH AMERICA             277

13.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 279

13.2.2      US           293

13.2.2.1  Rising adoption of advanced medical imaging and regulatory support to drive market       293

13.2.3      CANADA               307

13.2.3.1  Growing burden of chronic diseases and availability of research grants for AI to drive market growth 307

13.3         EUROPE               321

13.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      321

13.3.2      GERMANY           335

13.3.2.1  Advanced healthcare system and government efforts to drive growth    335

13.3.3      UK          348

13.3.3.1  Government support and new AI platform emergence to boost market    348

13.3.4      FRANCE                360

13.3.4.1  Thriving AI ecosystem and strategic partnerships to boost healthcare innovation           360

13.3.5      ITALY    374

13.3.5.1  Regulatory reforms, strategic investments, and aging population to propel growth   374

13.3.6      SPAIN    388

13.3.6.1  Established network of research centers to propel market                 388

13.3.7      REST OF EUROPE             402

13.4         ASIA PACIFIC     416

13.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 418

13.4.2      CHINA  432

13.4.2.1  Expanding AI applications in medical imaging and diagnostics to drive market growth             432

13.4.3      JAPAN   445

13.4.3.1  Strong healthcare infrastructure to drive uptake of advanced AI                 445

13.4.4      INDIA    458

13.4.4.1  Favorable government initiatives for R&D investments to drive market    458

13.4.5      REST OF ASIA PACIFIC   471

13.5         LATIN AMERICA                483

13.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 484

13.5.2      BRAZIL 497

13.5.2.1  AI initiatives to drive healthcare innovation and accessibility                 497

13.5.3      MEXICO                508

13.5.3.1  AI to revolutionize healthcare delivery and outcomes, focusing on accessibility, efficiency, and innovation             508

13.5.4      REST OF LATIN AMERICA             521

13.6         MIDDLE EAST & AFRICA                533

13.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 534

13.6.2      GCC COUNTRIES              547

13.6.2.1  AI-driven innovations and rise in healthcare investments to propel market growth           547

13.6.3      REST OF THE MIDDLE EAST & AFRICA   561

14            COMPETITIVE LANDSCAPE         574

14.1         INTRODUCTION              574

14.2         KEY PLAYER STRATEGY/RIGHT TO WIN                574

14.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET                 575

14.3         REVENUE ANALYSIS, 2020–2024  578

14.4         MARKET SHARE ANALYSIS, 2024                 579

14.4.1      RANKING OF KEY MARKET PLAYERS       582

14.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 583

14.5.1      STARS   583

14.5.2      EMERGING LEADERS     583

14.5.3      PERVASIVE PLAYERS      583

14.5.4      PARTICIPANTS 583

14.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         585

14.5.5.1  Company footprint               585

14.5.5.2  Regional footprint                 586

14.5.5.3  Application footprint            587

14.5.5.4  Tool footprint        588

14.5.5.5  Function footprint                589

14.5.5.6  Offering footprint 590

14.5.5.7  Deployment footprint          591

14.5.5.8  End-user footprint                592

14.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        593

14.6.1      PROGRESSIVE COMPANIES         593

14.6.2      RESPONSIVE COMPANIES            593

14.6.3      DYNAMIC COMPANIES  593

14.6.4      STARTING BLOCKS         593

14.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 595

14.6.5.1  Detailed list of key startups/SMEs    595

14.6.5.2  Company footprint (startups/SMEs)                596

14.7         COMPANY VALUATION AND FINANCIAL METRICS                 596

14.7.1      FINANCIAL METRICS      596

14.7.2      COMPANY VALUATION 597

14.8         BRAND/PRODUCT COMPARISON             598

14.9         COMPETITIVE SCENARIO             599

14.9.1      PRODUCT LAUNCHES   599

14.9.2      DEALS  600

14.9.3      OTHER DEVELOPMENTS              601

15            COMPANY PROFILES      603

15.1         KEY PLAYERS     603

15.1.1      KONINKLIJKE PHILIPS N.V.          603

15.1.1.1  Business overview 603

15.1.1.2  Products & services offered                 604

15.1.1.3  Recent developments           607

15.1.1.3.1                Product launches  607

15.1.1.3.2                Deals      608

15.1.1.3.3                Expansions             610

15.1.1.3.4                Other developments             611

15.1.1.4  MnM view              611

15.1.1.4.1                Right to win           611

15.1.1.4.2                Strategic choices   612

15.1.1.4.3                Weaknesses & competitive threats     612

15.1.2      MICROSOFT CORPORATION      613

15.1.2.1  Business overview 613

15.1.2.2  Products & services offered                 615

15.1.2.3  Recent developments           616

15.1.2.3.1                Product launches  616

15.1.2.3.2                Deals      617

15.1.2.4  MnM view              619

15.1.2.4.1                Right to win           619

15.1.2.4.2                Strategic choices   619

15.1.2.4.3                Weaknesses & competitive threats     620

15.1.3      NVIDIA CORPORATION 620

15.1.3.1  Business overview 620

15.1.3.2  Products & services offered                 621

15.1.3.3  Recent developments           622

15.1.3.3.1                Product launches  622

15.1.3.3.2                Deals      623

15.1.3.4  MnM view              624

15.1.3.4.1                Right to win           624

15.1.3.4.2                Strategic choices   624

15.1.3.4.3                Weaknesses & competitive threats     624

15.1.4      SIEMENS HEALTHINEERS AG      625

15.1.4.1  Business overview 625

15.1.4.2  Products & services offered                 627

15.1.4.3  Recent developments           628

15.1.4.3.1                Product launches & enhancements    628

15.1.4.3.2                Deals      628

15.1.4.3.3                Other developments             630

15.1.4.4  MnM view              630

15.1.4.4.1                Right to win           630

15.1.4.4.2                Strategic choices   630

15.1.4.4.3                Weaknesses & competitive threats     631

15.1.5      GE HEALTHCARE             632

15.1.5.1  Business overview 632

15.1.5.2  Products & services offered                 634

15.1.5.3  Recent developments           635

15.1.5.3.1                Deals      635

15.1.5.3.2                Other developments             636

15.1.5.4  MnM view              636

15.1.5.4.1                Right to win           636

15.1.5.4.2                Strategic choices   637

15.1.5.4.3                Weaknesses & competitive threats     637

15.1.6      EPIC SYSTEMS CORPORATION  638

15.1.6.1  Business overview 638

15.1.6.2  Products & services offered                 638

15.1.6.3  Recent developments           639

15.1.6.3.1                Deals      639

15.1.7      ORACLE CORPORATION               640

15.1.7.1  Business overview 640

15.1.7.2  Products & services offered                 641

15.1.7.3  Recent developments           642

15.1.7.3.1                Product launches  642

15.1.7.3.2                Deals      643

15.1.7.3.3                Expansions             644

15.1.8      VERADIGM INC.                645

15.1.8.1  Business overview 645

15.1.8.2  Products & services offered                 646

15.1.8.3  Recent developments           647

15.1.8.3.1                Deals      647

15.1.9      AMAZON WEB SERVICES, INC.    648

15.1.9.1  Business overview 648

15.1.9.2  Products & services offered                 649

15.1.9.3  Recent developments           650

15.1.9.3.1                Product launches  650

15.1.9.3.2                Deals      651

15.1.9.3.3                Expansions             652

15.1.10   MERATIVE           653

15.1.10.1                 Business overview 653

15.1.10.2                 Products & services offered                 653

15.1.10.3                 Recent developments           654

15.1.10.3.1             Product launches  654

15.1.10.3.2             Deals      654

15.1.11   IBM        655

15.1.11.1                 Business overview 655

15.1.11.2                 Products & services offered                 656

15.1.11.3                 Recent developments           657

15.1.11.3.1             Deals      657

15.1.12   MEDTRONIC      658

15.1.12.1                 Business overview 658

15.1.12.2                 Products & services offered                 659

15.1.12.3                 Recent developments           660

15.1.12.3.1             Product launches  660

15.1.12.3.2             Deals      661

15.1.13   GOOGLE              662

15.1.13.1                 Business overview 662

15.1.13.2                 Products & services offered                 663

15.1.13.3                 Recent developments           664

15.1.13.3.1             Product launches  664

15.1.13.3.2             Deals      665

15.1.13.3.3             Other developments             667

15.1.14   SOPHIA GENETICS          668

15.1.14.1                 Business overview 668

15.1.14.2                 Products & services offered                 669

15.1.14.3                 Recent developments           669

15.1.14.3.1             Product launches  669

15.1.14.3.2             Deals      670

15.1.14.3.3             Other developments             671

15.1.15   JOHNSON & JOHNSON SERVICES, INC.   672

15.1.15.1                 Business overview 672

15.1.15.2                 Products & services offered                 673

15.1.15.3                 Recent developments           674

15.1.15.3.1             Other developments             674

15.1.15.3.2             Deals      674

15.1.16   TEMPUS AI, INC.               675

15.1.16.1                 Business overview 675

15.1.16.2                 Products & services offered                 676

15.1.16.3                 Recent developments           677

15.1.16.3.1             Product launches  677

15.1.16.3.2             Deals      678

15.1.17   CONCERTAI       679

15.1.17.1                 Business overview 679

15.1.17.2                 Products & services offered                 679

15.1.17.3                 Recent developments           680

15.1.17.3.1             Product launches  680

15.1.17.3.2             Deals      681

15.1.18   SOLVENTUM CORPORATION     683

15.1.18.1                 Business overview 683

15.1.18.2                 Products & services offered                 684

15.1.18.3                 Recent developments           685

15.1.18.3.1             Deals      685

15.1.18.3.2             Other developments             685

15.1.19   COGNIZANT      686

15.1.19.1                 Business overview 686

15.1.19.2                 Products & services offered                 688

15.1.19.3                 Recent developments           688

15.1.19.3.1             Product launches  688

15.1.19.3.2             Deals      689

15.1.20   VIZ.AI, INC.         690

15.1.20.1                 Business overview 690

15.1.20.2                 Products & services offered                 690

15.1.20.3                 Recent developments           691

15.1.20.3.1             Product launches  691

15.1.20.3.2             Deals      692

15.1.20.3.3             Other developments             694

15.1.21   RIVERAIN TECHNOLOGIES          695

15.1.21.1                 Business overview 695

15.1.21.2                 Products & services offered                 695

15.1.21.3                 Recent developments           696

15.1.21.3.1             Deals      696

15.2         OTHER PLAYERS              697

15.2.1      QVENTUS            697

15.2.2      QURE.AI               698

15.2.3      ATOMWISE INC.                699

15.2.4      ENLITIC                700

15.2.5      SEGMED               700

16            APPENDIX           701

16.1         DISCUSSION GUIDE        701

16.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                708

16.3         CUSTOMIZATION OPTIONS        710

16.4         RELATED REPORTS         710

16.5         AUTHOR DETAILS           711

LIST OF TABLES

TABLE 1                INCLUSIONS & EXCLUSIONS       60

TABLE 2                EXCHANGE RATES UTILIZED FOR CONVERSION TO USD                64

TABLE 3                STUDY ASSUMPTIONS  77

TABLE 4                AI IN HEALTHCARE MARKET: RISK ASSESSMENT                 78

TABLE 5                AI IN HEALTHCARE MARKET: IMPACT ANALYSIS                 90

TABLE 6                COMPANIES AND THEIR ROLES IN AI IN HEALTHCARE ECOSYSTEM         109

TABLE 7                KEY PATENTS IN AI IN HEALTHCARE MARKET                 112

TABLE 8                AI IN HEALTHCARE MARKET: LIST OF CONFERENCES & EVENTS, 2025–2026       114

TABLE 9                NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  118

TABLE 10              EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 119

TABLE 11              ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  119

TABLE 12              NORTH AMERICA             120

TABLE 13              EUROPE               122

TABLE 14              ASIA PACIFIC     122

TABLE 15              MIDDLE EAST & AFRICA                123

TABLE 16              LATIN AMERICA                124

TABLE 17              ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: PORTER’S

FIVE FORCES ANALYSIS 124

TABLE 18              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS  127

TABLE 19              KEY BUYING CRITERIA FOR TOP THREE END USERS   128

TABLE 20              UNMET NEEDS IN AI IN HEALTHCARE MARKET                 129

TABLE 21              END-USER EXPECTATIONS IN AI IN HEALTHCARE MARKET 130

TABLE 22              US ADJUSTED RECIPROCAL TARIFF RATES                 142

TABLE 23              KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR AI IN REMOTE PATIENT MONITORING        143

TABLE 24              EXPECTED CHANGE IN PRICES AND LIKELY IMPACT ON END-USE MARKET DUE TO TARIFF IMPACT                 144

TABLE 1                AI IN HEALTHCARE MARKET, BY OFFERING, 2023–2030 (USD MILLION)            148

TABLE 2                AI IN HEALTHCARE MARKET FOR INTEGRATED SOLUTIONS, BY REGION,

2023–2030 (USD MILLION)            149

TABLE 3                AI IN HEALTHCARE MARKET FOR NICHE/POINT SOLUTIONS, BY REGION,

2023–2030 (USD MILLION)            150

TABLE 4                AI IN HEALTHCARE MARKET FOR AI TECHNOLOGIES, BY REGION,

2023–2030 (USD MILLION)            151

TABLE 5                AI IN HEALTHCARE MARKET FOR SERVICES, BY REGION,

2023–2030 (USD MILLION)            152

TABLE 6                AI IN HEALTHCARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)            154

TABLE 7                AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION FUNCTIONS,

BY TYPE, 2023–2030 (USD MILLION)         155

TABLE 8                AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION FUNCTIONS,

BY REGION, 2023–2030 (USD MILLION)   155

TABLE 9                AI IN HEALTHCARE MARKET FOR PRE-SCREENING, BY REGION,

2023–2030 (USD MILLION)            156

TABLE 10              AI IN HEALTHCARE MARKET FOR IVD, BY REGION, 2023–2030 (USD MILLION)          157

TABLE 11              AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            157

TABLE 12              AI IN HEALTHCARE MARKET FOR IMMUNOASSAYS, BY REGION,

2023–2030 (USD MILLION)            158

TABLE 13              AI IN HEALTHCARE MARKET FOR CLINICAL CHEMISTRY, BY REGION,

2023–2030 (USD MILLION)            159

TABLE 14              AI IN HEALTHCARE MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION,

2023–2030 (USD MILLION)            159

TABLE 15              AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023–2030 (USD MILLION)              160

TABLE 16              AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS & INTERPRETATION,

BY REGION, 2023–2030 (USD MILLION)   161

TABLE 17              AI IN HEALTHCARE MARKET FOR BIOMARKER DISCOVERY & ANALYSIS,

BY REGION, 2023–2030 (USD MILLION)   161

TABLE 18              AI IN HEALTHCARE MARKET FOR OTHER IVD APPLICATIONS, BY REGION,

2023–2030 (USD MILLION)            162

TABLE 19              AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY REGION,

2023–2030 (USD MILLION)            163

TABLE 20              AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION,

2023–2030 (USD MILLION)            163

TABLE 21              AI IN HEALTHCARE MARKET FOR DISEASE INTERPRETATION & REPORT ANALYSIS, BY REGION, 2023–2030 (USD MILLION) 164

TABLE 22              AI IN HEALTHCARE MARKET FOR IMAGE CAPTIONING & ANNOTATION, BY REGION, 2023–2030 (USD MILLION)            165

TABLE 23              AI IN HEALTHCARE MARKET FOR IMAGE RECONSTRUCTION, BY REGION,

2023–2030 (USD MILLION)            165

TABLE 24              AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING APPLICATIONS,

BY REGION, 2023–2030 (USD MILLION)   166

TABLE 25              AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY,

2023–2030 (USD MILLION)            167

TABLE 26              AI IN HEALTHCARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI),

BY REGION, 2023–2030 (USD MILLION)   168

TABLE 27              AI IN HEALTHCARE MARKET FOR COMPUTED TOMOGRAPHY (CT),

BY REGION, 2023–2030 (USD MILLION)   169

TABLE 28              AI IN HEALTHCARE MARKET FOR X-RAY IMAGING, BY REGION,

2023–2030 (USD MILLION)            169

TABLE 29              AI IN HEALTHCARE MARKET FOR ULTRASOUND, BY REGION,

2023–2030 (USD MILLION)            170

TABLE 30              AI IN HEALTHCARE MARKET FOR NUCLEAR IMAGING (PET & SPECT),

BY REGION, 2023–2030 (USD MILLION)   171

TABLE 31              AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING MODALITIES,

BY REGION, 2023–2030 (USD MILLION)   172

TABLE 32              AI IN HEALTHCARE MARKET FOR RISK ASSESSMENT & PATIENT STRATIFICATION, BY REGION, 2023–2030 (USD MILLION)       173

TABLE 33              AI IN HEALTHCARE MARKET FOR DRUG ALLERGY ALERTING, BY REGION,

2023–2030 (USD MILLION)            174

TABLE 34              AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY REGION, 2023–2030 (USD MILLION)            174

TABLE 35              AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY TYPE, 2023–2030 (USD MILLION)       175

TABLE 36              AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY REGION, 2023–2030 (USD MILLION)            176

TABLE 37              AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING,

BY TYPE, 2023–2030 (USD MILLION)         176

TABLE 38              AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING,

BY REGION, 2023–2030 (USD MILLION)   177

TABLE 39              AI IN HEALTHCARE MARKET FOR PRECISION MEDICINE & GENOMIC ANALYSIS,

BY REGION, 2023–2030 (USD MILLION)   178

TABLE 40              AI IN HEALTHCARE MARKET FOR PREDICTIVE MODELS FOR TREATMENT RESPONSE, BY REGION, 2023–2030 (USD MILLION) 179

TABLE 41              AI IN HEALTHCARE MARKET FOR TREATMENT RECOMMENDATION SYSTEMS,

BY REGION, 2023–2030 (USD MILLION)   179

TABLE 42              AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE,

2023–2030 (USD MILLION)            180

TABLE 43              AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY REGION, 2023–2030 (USD MILLION)            180

TABLE 44              AI IN HEALTHCARE MARKET FOR DRUG RESPONSE PREDICTION, BY REGION, 2023–2030 (USD MILLION)                 181

TABLE 45              AI IN HEALTHCARE MARKET FOR DOSING & ADMINISTRATION, BY REGION,

2023–2030 (USD MILLION)            182

TABLE 46              AI IN HEALTHCARE MARKET FOR OTHER PHARMACOLOGICAL THERAPY FUNCTIONS, BY REGION, 2023–2030 (USD MILLION)       182

TABLE 47              AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,

2023–2030 (USD MILLION)            183

TABLE 48              AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY REGION,

2023–2030 (USD MILLION)            183

TABLE 49              AI IN HEALTHCARE MARKET FOR PREOPERATIVE IMAGING & 3D MODELING,

BY REGION, 2023–2030 (USD MILLION)   184

TABLE 50              AI IN HEALTHCARE MARKET FOR INTRAOPERATIVE GUIDANCE & ROBOTICS,

BY REGION, 2023–2030 (USD MILLION)   185

TABLE 51              AI IN HEALTHCARE MARKET FOR POSTOPERATIVE ANALYSIS & RECOVERY,

BY REGION, 2023–2030 (USD MILLION)   186

TABLE 52              AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,

2023–2030 (USD MILLION)            186

TABLE 53              AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY REGION,

2023–2030 (USD MILLION)            187

TABLE 54              AI IN HEALTHCARE MARKET FOR MOTION SYNCHRONIZATION & AUTO CONTOURING, BY REGION, 2023–2030 (USD MILLION)       187

TABLE 55              AI IN HEALTHCARE MARKET FOR REAL-TIME ADAPTIVE TREATMENT DELIVERY,

BY REGION, 2023–2030 (USD MILLION)   188

TABLE 56              AI IN HEALTHCARE MARKET FOR RESPONSE ASSESSMENT & QUALITY ASSURANCE, BY REGION, 2023–2030 (USD MILLION) 189

TABLE 57              AI IN HEALTHCARE MARKET FOR OTHER RADIATION THERAPY FUNCTIONS,

BY REGION, 2023–2030 (USD MILLION)   189

TABLE 58              AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY,

BY TYPE, 2023–2030 (USD MILLION)         190

TABLE 59              AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY,

BY REGION, 2023–2030 (USD MILLION)   190

TABLE 60              AI IN HEALTHCARE MARKET FOR VIRTUAL COUNSELING & CHATBOTS, BY REGION, 2023–2030 (USD MILLION)            191

TABLE 61              AI IN HEALTHCARE MARKET FOR PROGRESS MONITORING & FEEDBACK,

BY REGION, 2023–2030 (USD MILLION)   192

TABLE 62              AI IN HEALTHCARE MARKET FOR FOLLOW-UP & LONG-TERM SUPPORT,

BY REGION, 2023–2030 (USD MILLION)   193

TABLE 63              AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,

2023–2030 (USD MILLION)            193

TABLE 64              AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY REGION,

2023–2030 (USD MILLION)            194

TABLE 65              AI IN HEALTHCARE MARKET FOR REAL-TIME PATIENT DATA MONITORING,

BY REGION, 2023–2030 (USD MILLION)   194

TABLE 66              AI IN HEALTHCARE MARKET FOR RESPONSE & SIDE-EFFECT PREDICTION,

BY REGION, 2023–2030 (USD MILLION)   195

TABLE 67              AI IN HEALTHCARE MARKET FOR RELAPSE PREDICTION & LONG-TERM MANAGEMENT, BY REGION, 2023–2030 (USD MILLION)       196

TABLE 68              AI IN HEALTHCARE MARKET FOR OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY REGION, 2023–2030 (USD MILLION)          196

TABLE 69              AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY TYPE, 2023–2030 (USD MILLION)            197

TABLE 70              AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY REGION, 2023–2030 (USD MILLION)          198

TABLE 71              AI IN HEALTHCARE MARKET FOR SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE, BY REGION, 2023–2030 (USD MILLION) 198

TABLE 72              AI IN HEALTHCARE MARKET FOR TELEHEALTH & REMOTE PATIENT MONITORING, BY REGION, 2023–2030 (USD MILLION)            199

TABLE 73              AI IN HEALTHCARE MARKET FOR HEALTHCARE ASSISTANCE ROBOTS,

BY REGION, 2023–2030 (USD MILLION)   200

TABLE 74              AI IN HEALTHCARE MARKET FOR MEDICATION REMINDERS, BY REGION,

2023–2030 (USD MILLION)            201

TABLE 75              AI IN HEALTHCARE MARKET FOR PATIENT EDUCATION & EMPOWERMENT,

BY REGION, 2023–2030 (USD MILLION)   202

TABLE 76              AI IN HEALTHCARE MARKET FOR OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY REGION, 2023–2030 (USD MILLION)   202

TABLE 77              AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE FUNCTIONS, BY TYPE, 2023–2030 (USD MILLION)              203

TABLE 78              AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE FUNCTIONS, BY REGION, 2023–2030 (USD MILLION)        203

TABLE 79              AI IN HEALTHCARE MARKET FOR RECURRENCE MONITORING, BY REGION,

2023–2030 (USD MILLION)            204

TABLE 80              AI IN HEALTHCARE MARKET FOR LONG-TERM OUTCOME PREDICTION, BY REGION, 2023–2030 (USD MILLION)                 205

TABLE 81              AI IN HEALTHCARE MARKET FOR MENTAL HEALTH & SUPPORT SYSTEMS,

BY REGION, 2023–2030 (USD MILLION)   205

TABLE 82              AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT FUNCTIONS,

BY TYPE, 2023–2030 (USD MILLION)         206

TABLE 83              AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT FUNCTIONS,

BY REGION, 2023–2030 (USD MILLION)   206

TABLE 84              AI IN HEALTHCARE MARKET FOR EPRESCRIBING, BY REGION,

2023–2030 (USD MILLION)            207

TABLE 85              AI IN HEALTHCARE MARKET FOR MEDICATION MANAGEMENT, BY REGION,

2023–2030 (USD MILLION)            208

TABLE 86              AI IN HEALTHCARE MARKET FOR PHARMACY AUDIT & ANALYSIS, BY REGION, 2023–2030 (USD MILLION)                 209

TABLE 87              AI IN HEALTHCARE MARKET FOR OTHER PHARMACY MANAGEMENT FUNCTIONS, BY REGION, 2023–2030 (USD MILLION) 209

TABLE 88              AI IN HEALTHCARE MARKET FOR DATA MANAGEMENT & ANALYTICS FUNCTIONS, BY REGION, 2023–2030 (USD MILLION)       210

TABLE 89              AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE,

2023–2030 (USD MILLION)            211

TABLE 90              AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY REGION,

2023–2030 (USD MILLION)            212

TABLE 91              AI IN HEALTHCARE MARKET FOR PATIENT REGISTRATION & SCHEDULING,

BY REGION, 2023–2030 (USD MILLION)   213

TABLE 92              AI IN HEALTHCARE MARKET FOR PATIENT ELIGIBILITY & AUTHORIZATION,

BY REGION, 2023–2030 (USD MILLION)   214

TABLE 93              AI IN HEALTHCARE MARKET FOR BILLING & CLAIMS MANAGEMENT, BY REGION, 2023–2030 (USD MILLION)                 215

TABLE 94              AI IN HEALTHCARE MARKET FOR WORKFORCE MANAGEMENT, BY REGION,

2023–2030 (USD MILLION)            216

TABLE 95              AI IN HEALTHCARE MARKET FOR SUPPLY CHAIN & INVENTORY MANAGEMENT,

BY REGION, 2023–2030 (USD MILLION)   217

TABLE 96              AI IN HEALTHCARE MARKET FOR COMPLIANCE & DOCUMENTATION,

BY REGION, 2023–2030 (USD MILLION)   218

TABLE 97              AI IN HEALTHCARE MARKET FOR HEALTHCARE WORKFLOW MANAGEMENT,

BY REGION, 2023–2030 (USD MILLION)   219

TABLE 98              AI IN HEALTHCARE MARKET FOR ASSET MANAGEMENT, BY REGION,

2023–2030 (USD MILLION)            220

TABLE 99              AI IN HEALTHCARE MARKET FOR CUSTOMER RELATIONSHIP MANAGEMENT,

BY REGION, 2023–2030 (USD MILLION)   221

TABLE 100            AI IN HEALTHCARE MARKET FOR FRAUD DETECTION & RISK MANAGEMENT,

BY REGION, 2023–2030 (USD MILLION)   222

TABLE 101            AI IN HEALTHCARE MARKET FOR CYBERSECURITY, BY REGION,

2023–2030 (USD MILLION)            223

TABLE 102            AI IN HEALTHCARE MARKET FOR OTHER ADMINISTRATIVE FUNCTIONS,

BY REGION, 2023–2030 (USD MILLION)   223

TABLE 103            AI IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            225

TABLE 104            AI IN HEALTHCARE MARKET FOR CLINICAL APPLICATIONS, BY REGION, CAGR (2025–2030)   226

TABLE 105            AI IN HEALTHCARE MARKET FOR NON-CLINICAL APPLICATIONS, BY REGION,

2023–2030 (USD MILLION)            228

TABLE 106            AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            230

TABLE 107            AI IN HEALTHCARE MARKET FOR ON-PREMISE MODELS, BY REGION,

2023–2030 (USD MILLION)            231

TABLE 108            AI IN HEALTHCARE MARKET FOR CLOUD-BASED MODELS, BY REGION,

2023–2030 (USD MILLION)            232

TABLE 109            AI IN HEALTHCARE MARKET FOR HYBRID MODELS, BY REGION,

CAGR (2025–2030)              233

TABLE 110            AI IN HEALTHCARE MARKET, BY TOOL, 2023–2030 (USD MILLION)       235

TABLE 111            AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,

2023–2030 (USD MILLION)            236

TABLE 112            AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY REGION,

2023–2030 (USD MILLION)            237

TABLE 113            AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,

2023–2030 (USD MILLION)            238

TABLE 114            AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY REGION,

2023–2030 (USD MILLION)            239

TABLE 115            AI IN HEALTHCARE MARKET FOR CONVOLUTIONAL NEURAL NETWORKS (CNN),

BY REGION, 2023–2030 (USD MILLION)   239

TABLE 116            AI IN HEALTHCARE MARKET FOR RECURRENT NEURAL NETWORKS (RNN),

BY REGION, 2023–2030 (USD MILLION)   240

TABLE 117            AI IN HEALTHCARE MARKET FOR GENERATIVE ADVERSARIAL NETWORKS (GAN),

BY REGION, 2023–2030 (USD MILLION)   241

TABLE 118            AI IN HEALTHCARE MARKET FOR GRAPH NEURAL NETWORKS (GNN), BY REGION, 2023–2030 (USD MILLION)            241

TABLE 119            AI IN HEALTHCARE MARKET FOR OTHER DEEP LEARNING TOOLS, BY REGION, 2023–2030 (USD MILLION)                 242

TABLE 120            AI IN HEALTHCARE MARKET FOR SUPERVISED LEARNING, BY REGION,

2023–2030 (USD MILLION)            243

TABLE 121            AI IN HEALTHCARE MARKET FOR REINFORCEMENT LEARNING, BY REGION,

2023–2030 (USD MILLION)            244

TABLE 122            AI IN HEALTHCARE MARKET FOR UNSUPERVISED LEARNING, BY REGION,

2023–2030 (USD MILLION)            245

TABLE 123            AI IN HEALTHCARE MARKET FOR OTHER MACHINE LEARNING TOOLS,

BY REGION, 2023–2030 (USD MILLION)   245

TABLE 124            AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING (NLP),

BY TYPE, 2023–2030 (USD MILLION)         246

TABLE 125            AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING (NLP),

BY REGION, 2023–2030 (USD MILLION)   247

TABLE 126            AI IN HEALTHCARE MARKET FOR SENTIMENT ANALYSIS, BY REGION,

2023–2030 (USD MILLION)            247

TABLE 127            AI IN HEALTHCARE MARKET FOR PATTERN & IMAGE RECOGNITION,

BY REGION, 2023–2030 (USD MILLION)   248

TABLE 128            AI IN HEALTHCARE MARKET FOR AUTO CODING, BY REGION,

2023–2030 (USD MILLION)            249

TABLE 129            AI IN HEALTHCARE MARKET FOR CLASSIFICATION & CATEGORIZATION, BY REGION, 2023–2030 (USD MILLION) 249

TABLE 130            AI IN HEALTHCARE MARKET FOR TEXT ANALYTICS, BY REGION,

2023–2030 (USD MILLION)            250

TABLE 131            AI IN HEALTHCARE MARKET FOR SPEECH RECOGNITION, BY REGION,

2023–2030 (USD MILLION)            251

TABLE 132            AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE,

2023–2030 (USD MILLION)            252

TABLE 133            AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY REGION, 2023–2030 (USD MILLION)                 252

TABLE 134            AI IN HEALTHCARE MARKET FOR DEVICE CONTEXT, BY REGION,

2023–2030 (USD MILLION)            253

TABLE 135            AI IN HEALTHCARE MARKET FOR USER CONTEXT, BY REGION,

2023–2030 (USD MILLION)            254

TABLE 136            AI IN HEALTHCARE MARKET FOR PHYSICAL CONTEXT, BY REGION,

2023–2030 (USD MILLION)            255

TABLE 137            AI IN HEALTHCARE MARKET FOR GENERATIVE AI, BY REGION,

2023–2030 (USD MILLION)            256

TABLE 138            AI IN HEALTHCARE MARKET FOR COMPUTER VISION, BY REGION,

2023–2030 (USD MILLION)            257

TABLE 139            AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS, BY REGION,

2023–2030 (USD MILLION)            258

TABLE 140            AI IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION)            260

TABLE 141            AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,

2023–2030 (USD MILLION)            262

TABLE 142            AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION,

2023–2030 (USD MILLION)            262

TABLE 143            AI IN HEALTHCARE MARKET FOR HOSPITALS, BY REGION,

2023–2030 (USD MILLION)            264

TABLE 144            AI IN HEALTHCARE MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2023–2030 (USD MILLION)            265

TABLE 145            AI IN HEALTHCARE MARKET FOR HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES, BY REGION, 2023–2030 (USD MILLION)          266

TABLE 146            AI IN HEALTHCARE MARKET FOR DIAGNOSTIC & IMAGING CENTERS,

BY REGION, 2023–2030 (USD MILLION)   267

TABLE 147            AI IN HEALTHCARE MARKET FOR PHARMACIES, BY REGION,

2023–2030 (USD MILLION)            268

TABLE 148            AI IN HEALTHCARE MARKET FOR OTHER HEALTHCARE PROVIDERS,

BY REGION, 2023–2030 (USD MILLION)   269

TABLE 149            AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,

2023–2030 (USD MILLION)            270

TABLE 150            AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY REGION,

2023–2030 (USD MILLION)            270

TABLE 151            AI IN HEALTHCARE MARKET FOR PUBLIC PAYERS, BY REGION,

2023–2030 (USD MILLION)            271

TABLE 152            AI IN HEALTHCARE MARKET FOR PRIVATE PAYERS, BY REGION,

2023–2030 (USD MILLION)            272

TABLE 153            AI IN HEALTHCARE MARKET FOR PATIENTS, BY REGION,

2023–2030 (USD MILLION)            273

TABLE 154            AI IN HEALTHCARE MARKET FOR OTHER END USERS, BY REGION,

2023–2030 (USD MILLION)            274

TABLE 155            AI IN HEALTHCARE MARKET, BY REGION, 2023–2030 (USD MILLION)       276

TABLE 156            NORTH AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            279

TABLE 157            NORTH AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING,

2023–2030 (USD MILLION)            280

TABLE 158            NORTH AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            280

TABLE 159            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023–2030 (USD MILLION)            281

TABLE 160            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            281

TABLE 161            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,

2023–2030 (USD MILLION)            282

TABLE 162            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY APPLICATION, 2023–2030 (USD MILLION)       282

TABLE 163            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY MODALITY, 2023–2030 (USD MILLION)             283

TABLE 164            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)            283

TABLE 165            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION)       284

TABLE 166            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023–2030 (USD MILLION)            284

TABLE 167            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         285

TABLE 168            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         285

TABLE 169            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION)            286

TABLE 170            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY,

BY TYPE, 2023–2030 (USD MILLION)         286

TABLE 171            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)                287

TABLE 172            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)         287

TABLE 173            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,

BY TYPE, 2023–2030 (USD MILLION)         288

TABLE 174            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023–2030 (USD MILLION)            288

TABLE 175            NORTH AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            289

TABLE 176            NORTH AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            289

TABLE 177            NORTH AMERICA: AI IN HEALTHCARE MARKET, BY TOOL,

2023–2030 (USD MILLION)            290

TABLE 178            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING,

BY TYPE, 2023–2030 (USD MILLION)         290

TABLE 179            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING,

BY TYPE, 2023–2030 (USD MILLION)         291

TABLE 180            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 291

TABLE 181            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023–2030 (USD MILLION)            292

TABLE 182            NORTH AMERICA: AI IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            292

TABLE 183            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2023–2030 (USD MILLION)         293

TABLE 184            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2023–2030 (USD MILLION)         293

TABLE 185            US: AI IN HEALTHCARE MARKET, BY OFFERING, 2023–2030 (USD MILLION)            294

TABLE 186            US: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)            295

TABLE 187            US: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,

BY TYPE, 2023–2030 (USD MILLION)         295

TABLE 188            US: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            296

TABLE 189            US: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,

2023–2030 (USD MILLION)            296

TABLE 190            US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY APPLICATION, 2023–2030 (USD MILLION)       296

TABLE 191            US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY,

2023–2030 (USD MILLION)            297

TABLE 192            US: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)       297

TABLE 193            US: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING,

BY TYPE, 2023–2030 (USD MILLION)         298

TABLE 194            US: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         298

TABLE 195            US: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,

2023–2030 (USD MILLION)            298

TABLE 196            US: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,

2023–2030 (USD MILLION)            299

TABLE 197            US: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION) 299

TABLE 198            US: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,

2023–2030 (USD MILLION)            300

TABLE 199            US: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION) 300

TABLE 200            US: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)            301

TABLE 201            US: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE,

2023–2030 (USD MILLION)            301

TABLE 202            US: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,

BY TYPE, 2023–2030 (USD MILLION)         302

TABLE 203            US: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              302

TABLE 204            US: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            303

TABLE 205            US: AI IN HEALTHCARE MARKET, BY TOOL, 2023–2030 (USD MILLION)            303

TABLE 206            US: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,

2023–2030 (USD MILLION)            304

TABLE 207            US: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,

2023–2030 (USD MILLION)            304

TABLE 208            US: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,

BY TYPE, 2023–2030 (USD MILLION)         305

TABLE 209            US: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023–2030 (USD MILLION)            305

TABLE 210            US: AI IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION)            306

TABLE 211            US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,

2023–2030 (USD MILLION)            306

TABLE 212            US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,

2023–2030 (USD MILLION)            307

TABLE 213            CANADA: AI IN HEALTHCARE MARKET, BY OFFERING, 2023–2030 (USD MILLION)     308

TABLE 214            CANADA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)   308

TABLE 215            CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,

BY TYPE, 2023–2030 (USD MILLION)         309

TABLE 216            CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            309

TABLE 217            CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,

2023–2030 (USD MILLION)            310

TABLE 218            CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023–2030 (USD MILLION)            310

TABLE 219            CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023–2030 (USD MILLION)            311

TABLE 220            CANADA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)       311

TABLE 221            CANADA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION) 312

TABLE 222            CANADA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         312

TABLE 223            CANADA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,

2023–2030 (USD MILLION)            313

TABLE 224            CANADA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,

2023–2030 (USD MILLION)            313

TABLE 225            CANADA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION) 314

TABLE 226            CANADA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY,

BY TYPE, 2023–2030 (USD MILLION)         314

TABLE 227            CANADA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)            315

TABLE 228            CANADA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)                315

TABLE 229            CANADA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,

BY TYPE, 2023–2030 (USD MILLION)         316

TABLE 230            CANADA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,

BY TYPE, 2023–2030 (USD MILLION)         316

TABLE 231            CANADA: AI IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            317

TABLE 232            CANADA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            317

TABLE 233            CANADA: AI IN HEALTHCARE MARKET, BY TOOL, 2023–2030 (USD MILLION)              317

TABLE 234            CANADA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,

2023–2030 (USD MILLION)            318

TABLE 235            CANADA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,

2023–2030 (USD MILLION)            318

TABLE 236            CANADA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,

BY TYPE, 2023–2030 (USD MILLION)         319

TABLE 237            CANADA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,

BY TYPE, 2023–2030 (USD MILLION)         319

TABLE 238            CANADA: AI IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION)                320

TABLE 239            CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2023–2030 (USD MILLION)         320

TABLE 240            CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2023–2030 (USD MILLION)         320

TABLE 241            EUROPE: AI IN HEALTHCARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     322

TABLE 242            EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING, 2023–2030 (USD MILLION)     322

TABLE 243            EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)   323

TABLE 244            EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,

BY TYPE, 2023–2030 (USD MILLION)         323

TABLE 245            EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            324

TABLE 246            EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,

2023–2030 (USD MILLION)            324

TABLE 247            EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023–2030 (USD MILLION)            324

TABLE 248            EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023–2030 (USD MILLION)            325

TABLE 249            EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)       325

TABLE 250            EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION) 326

TABLE 251            EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         326

TABLE 252            EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,

2023–2030 (USD MILLION)            327

TABLE 253            EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,

2023–2030 (USD MILLION)            327

TABLE 254            EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION) 328

TABLE 255            EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,

2023–2030 (USD MILLION)            328

TABLE 256            EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)            329

TABLE 257            EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)                329

TABLE 258            EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)                 330

TABLE 259            EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,

BY TYPE, 2023–2030 (USD MILLION)         330

TABLE 260            EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            331

TABLE 261            EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            331

TABLE 262          EUROPE: AI IN HEALTHCARE MARKET, BY TOOL, 2023–2030 (USD MILLION)            331

TABLE 263            EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,

2023–2030 (USD MILLION)            332

TABLE 264            EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,

2023–2030 (USD MILLION)            332

TABLE 265            EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,

BY TYPE, 2023–2030 (USD MILLION)         333

TABLE 266            EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,

BY TYPE, 2023–2030 (USD MILLION)         333

TABLE 267            EUROPE: AI IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION)                334

TABLE 268            EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2023–2030 (USD MILLION)         334

TABLE 269            EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,

2023–2030 (USD MILLION)            335

TABLE 270            GERMANY: AI IN HEALTHCARE MARKET, BY OFFERING, 2023–2030 (USD MILLION)     336

TABLE 271            GERMANY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)   336

TABLE 272            GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,

BY TYPE, 2023–2030 (USD MILLION)         337

TABLE 273            GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            337

TABLE 274            GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,

2023–2030 (USD MILLION)            338

TABLE 275            GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY APPLICATION, 2023–2030 (USD MILLION)       338

TABLE 276            GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023–2030 (USD MILLION)            339

TABLE 277            GERMANY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)       339

TABLE 278            GERMANY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION) 340

TABLE 279            GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         340

TABLE 280            GERMANY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,

2023–2030 (USD MILLION)            340

TABLE 281            GERMANY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,

2023–2030 (USD MILLION)            341

TABLE 282            GERMANY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION) 341

TABLE 283            GERMANY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,

2023–2030 (USD MILLION)            341

TABLE 284            GERMANY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)            342

TABLE 285            GERMANY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)                342

TABLE 286            GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,

BY TYPE, 2023–2030 (USD MILLION)         343

TABLE 287            GERMANY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,

BY TYPE, 2023–2030 (USD MILLION)         343

TABLE 288            GERMANY: AI IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            344

TABLE 289            GERMANY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            344

TABLE 290            GERMANY: AI IN HEALTHCARE MARKET, BY TOOL, 2023–2030 (USD MILLION)              344

TABLE 291            GERMANY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,

2023–2030 (USD MILLION)            345

TABLE 292            GERMANY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,

2023–2030 (USD MILLION)            345

TABLE 293            GERMANY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023–2030 (USD MILLION)            346

TABLE 294            GERMANY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,

BY TYPE, 2023–2030 (USD MILLION)         346

TABLE 295            GERMANY: AI IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            347

TABLE 296            GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2023–2030 (USD MILLION)         347

TABLE 297            GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2023–2030 (USD MILLION)         348

TABLE 298            UK: AI IN HEALTHCARE MARKET, BY OFFERING, 2023–2030 (USD MILLION)            349

TABLE 299          UK: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)            349

TABLE 300            UK: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,

BY TYPE, 2023–2030 (USD MILLION)         350

TABLE 301            UK: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            350

TABLE 302            UK: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,

2023–2030 (USD MILLION)            351

TABLE 303            UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023–2030 (USD MILLION)            351

TABLE 304            UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY,

2023–2030 (USD MILLION)            352

TABLE 305            UK: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)       352

TABLE 306            UK: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING,

BY TYPE, 2023–2030 (USD MILLION)         353

TABLE 307            UK: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         353

TABLE 308            UK: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,

2023–2030 (USD MILLION)            353

TABLE 309            UK: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,

2023–2030 (USD MILLION)            354

TABLE 310            UK: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION) 354

TABLE 311            UK: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,

2023–2030 (USD MILLION)            354

TABLE 312            UK: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION) 355

TABLE 313            UK: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)            355

TABLE 314            UK: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE,

2023–2030 (USD MILLION)            356

TABLE 315            UK: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023–2030 (USD MILLION)            356

TABLE 316            UK: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              357

TABLE 317            UK: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            357

TABLE 318            UK: AI IN HEALTHCARE MARKET, BY TOOL, 2023–2030 (USD MILLION)            357

TABLE 319            UK: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,

2023–2030 (USD MILLION)            358

TABLE 320            UK: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,

2023–2030 (USD MILLION)            358

TABLE 321            UK: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,

BY TYPE, 2023–2030 (USD MILLION)         359

TABLE 322            UK: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,

BY TYPE, 2023–2030 (USD MILLION)         359

TABLE 323            UK: AI IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION)            359

TABLE 324            UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,

2023–2030 (USD MILLION)            360

TABLE 325            UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,

2023–2030 (USD MILLION)            360

TABLE 326            FRANCE: AI IN HEALTHCARE MARKET, BY OFFERING, 2023–2030 (USD MILLION)     361

TABLE 327            FRANCE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)   362

TABLE 328            FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,

BY TYPE, 2023–2030 (USD MILLION)         362

TABLE 329            FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            363

TABLE 330            FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,

2023–2030 (USD MILLION)            363

TABLE 331            FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023–2030 (USD MILLION)            363

TABLE 332            FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023–2030 (USD MILLION)            364

TABLE 333            FRANCE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)       364

TABLE 334            FRANCE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION) 365

TABLE 335            FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023–2030 (USD MILLION)            365

TABLE 336            FRANCE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,

2023–2030 (USD MILLION)            366

TABLE 337            FRANCE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,

2023–2030 (USD MILLION)            366

TABLE 338            FRANCE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION) 367

TABLE 339            FRANCE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,

2023–2030 (USD MILLION)            367

TABLE 340            FRANCE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)            368

TABLE 341            FRANCE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)                368

TABLE 342            FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)                 369

TABLE 343            FRANCE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,

BY TYPE, 2023–2030 (USD MILLION)         369

TABLE 344            FRANCE: AI IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            370

TABLE 345            FRANCE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            370

TABLE 346          FRANCE: AI IN HEALTHCARE MARKET, BY TOOL, 2023–2030 (USD MILLION)            370

TABLE 347            FRANCE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,

2023–2030 (USD MILLION)            371

TABLE 348            FRANCE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,

2023–2030 (USD MILLION)            371

TABLE 349            FRANCE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,

BY TYPE, 2023–2030 (USD MILLION)         372

TABLE 350            FRANCE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,

BY TYPE, 2023–2030 (USD MILLION)         372

TABLE 351            FRANCE: AI IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION)                373

TABLE 352            FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2023–2030 (USD MILLION)         373

TABLE 353            FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,

2023–2030 (USD MILLION)            373

TABLE 354            ITALY: AI IN HEALTHCARE MARKET, BY OFFERING, 2023–2030 (USD MILLION)     375

TABLE 355            ITALY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)   375

TABLE 356            ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023–2030 (USD MILLION)            376

TABLE 357            ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            376

TABLE 358            ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,

2023–2030 (USD MILLION)            377

TABLE 359            ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY APPLICATION, 2023–2030 (USD MILLION)       377

TABLE 360            ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY MODALITY, 2023–2030 (USD MILLION)             378

TABLE 361            ITALY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)       378

TABLE 362            ITALY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING,

BY TYPE, 2023–2030 (USD MILLION)         379

TABLE 363            ITALY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         379

TABLE 364            ITALY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,

2023–2030 (USD MILLION)            380

TABLE 365            ITALY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,

2023–2030 (USD MILLION)            380

TABLE 366            ITALY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION) 381

TABLE 367            ITALY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,

2023–2030 (USD MILLION)            381

TABLE 368            ITALY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)            382

TABLE 369            ITALY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)            382

TABLE 370            ITALY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)                 383

TABLE 371            ITALY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023–2030 (USD MILLION)            383

TABLE 372            ITALY: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              384

TABLE 373            ITALY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            384

TABLE 374            ITALY: AI IN HEALTHCARE MARKET, BY TOOL, 2023–2030 (USD MILLION)            384

TABLE 375            ITALY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,

2023–2030 (USD MILLION)            385

TABLE 376            ITALY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,

2023–2030 (USD MILLION)            385

TABLE 377            ITALY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,

BY TYPE, 2023–2030 (USD MILLION)         386

TABLE 378            ITALY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,

BY TYPE, 2023–2030 (USD MILLION)         386

TABLE 379            ITALY: AI IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION)                387

TABLE 380            ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,

2023–2030 (USD MILLION)            387

TABLE 381            ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,

2023–2030 (USD MILLION)            388

TABLE 382            SPAIN: AI IN HEALTHCARE MARKET, BY OFFERING, 2023–2030 (USD MILLION)     389

TABLE 383            SPAIN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)   389

TABLE 384            SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,

BY TYPE, 2023–2030 (USD MILLION)         390

TABLE 385            SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            390

TABLE 386            SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,

2023–2030 (USD MILLION)            391

TABLE 387            SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY APPLICATION, 2023–2030 (USD MILLION)       391

TABLE 388            SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY MODALITY, 2023–2030 (USD MILLION)             392

TABLE 389            SPAIN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)       392

TABLE 390            SPAIN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION) 393

TABLE 391            SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         393

TABLE 392            SPAIN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,

2023–2030 (USD MILLION)            394

TABLE 393            SPAIN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,

2023–2030 (USD MILLION)            394

TABLE 394            SPAIN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION) 395

TABLE 395            SPAIN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,

2023–2030 (USD MILLION)            395

TABLE 396            SPAIN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)            396

TABLE 397            SPAIN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)            396

TABLE 398            SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,

BY TYPE, 2023–2030 (USD MILLION)         397

TABLE 399            SPAIN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,

BY TYPE, 2023–2030 (USD MILLION)         397

TABLE 400            SPAIN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              398

TABLE 401            SPAIN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            398

TABLE 402            SPAIN: AI IN HEALTHCARE MARKET, BY TOOL, 2023–2030 (USD MILLION)            398

TABLE 403            SPAIN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,

2023–2030 (USD MILLION)            399

TABLE 404            SPAIN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,

2023–2030 (USD MILLION)            399

TABLE 405            SPAIN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,

BY TYPE, 2023–2030 (USD MILLION)         400

TABLE 406            SPAIN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,

BY TYPE, 2023–2030 (USD MILLION)         400

TABLE 407            SPAIN: AI IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION)                401

TABLE 408            SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)                 401

TABLE 409            SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,

2023–2030 (USD MILLION)            402

TABLE 410            REST OF EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING,

2023–2030 (USD MILLION)            403

TABLE 411            REST OF EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            403

TABLE 412            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023–2030 (USD MILLION)            404

TABLE 413            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            404

TABLE 414            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,

2023–2030 (USD MILLION)            405

TABLE 415            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY APPLICATION, 2023–2030 (USD MILLION)       405

TABLE 416            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY MODALITY, 2023–2030 (USD MILLION)             406

TABLE 417            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)            406

TABLE 418            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION)       407

TABLE 419            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023–2030 (USD MILLION)            407

TABLE 420            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         408

TABLE 421            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         408

TABLE 422            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION)            409

TABLE 423            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023–2030 (USD MILLION)                 409

TABLE 424            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)                410

TABLE 425            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)         410

TABLE 426            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,

BY TYPE, 2023–2030 (USD MILLION)         411

TABLE 427            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023–2030 (USD MILLION)            411

TABLE 428            REST OF EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            412

TABLE 429            REST OF EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            412

TABLE 430            REST OF EUROPE: AI IN HEALTHCARE MARKET, BY TOOL,

2023–2030 (USD MILLION)            412

TABLE 431            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING,

BY TYPE, 2023–2030 (USD MILLION)         413

TABLE 432            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING,

BY TYPE, 2023–2030 (USD MILLION)         413

TABLE 433            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 414

TABLE 434            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023–2030 (USD MILLION)            414

TABLE 435            REST OF EUROPE: AI IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            415

TABLE 436            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2023–2030 (USD MILLION)         415

TABLE 437            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2023–2030 (USD MILLION)         415

TABLE 438            ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            418

TABLE 439            ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING,

2023–2030 (USD MILLION)            419

TABLE 440            ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            419

TABLE 441            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023–2030 (USD MILLION)            420

TABLE 442            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            420

TABLE 443            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,

2023–2030 (USD MILLION)            421

TABLE 444            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY APPLICATION, 2023–2030 (USD MILLION)       421

TABLE 445            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY MODALITY, 2023–2030 (USD MILLION)             422

TABLE 446            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)       422

TABLE 447            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION) 423

TABLE 448            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         423

TABLE 449            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023–2030 (USD MILLION)                 424

TABLE 450            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023–2030 (USD MILLION)                 424

TABLE 451            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION) 425

TABLE 452            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,

2023–2030 (USD MILLION)            425

TABLE 453            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)            426

TABLE 454            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)                426

TABLE 455            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,

BY TYPE, 2023–2030 (USD MILLION)         427

TABLE 456            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,

BY TYPE, 2023–2030 (USD MILLION)         427

TABLE 457            ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            428

TABLE 458            ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            428

TABLE 459            ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL, 2023–2030 (USD MILLION)              429

TABLE 460            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING,

BY TYPE, 2023–2030 (USD MILLION)         429

TABLE 461            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,

2023–2030 (USD MILLION)            430

TABLE 462            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023–2030 (USD MILLION)            430

TABLE 463            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,

BY TYPE, 2023–2030 (USD MILLION)         431

TABLE 464            ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            431

TABLE 465            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2023–2030 (USD MILLION)         432

TABLE 466            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2023–2030 (USD MILLION)         432

TABLE 467            CHINA: AI IN HEALTHCARE MARKET, BY OFFERING, 2023–2030 (USD MILLION)     433

TABLE 468            CHINA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)   434

TABLE 469            CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,

BY TYPE, 2023–2030 (USD MILLION)         434

TABLE 470            CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            435

TABLE 471            CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,

2023–2030 (USD MILLION)            435

TABLE 472            CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY APPLICATION, 2023–2030 (USD MILLION)       435

TABLE 473            CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY MODALITY, 2023–2030 (USD MILLION)             436

TABLE 474            CHINA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)       436

TABLE 475            CHINA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION) 437

TABLE 476            CHINA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         437

TABLE 477            CHINA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,

2023–2030 (USD MILLION)            437

TABLE 478            CHINA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,

2023–2030 (USD MILLION)            438

TABLE 479            CHINA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION) 438

TABLE 480            CHINA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,

2023–2030 (USD MILLION)            438

TABLE 481            CHINA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)            439

TABLE 482            CHINA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)            439

TABLE 483            CHINA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,

BY TYPE, 2023–2030 (USD MILLION)         440

TABLE 484            CHINA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,

BY TYPE, 2023–2030 (USD MILLION)         440

TABLE 485            CHINA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              441

TABLE 486            CHINA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            441

TABLE 487            CHINA: AI IN HEALTHCARE MARKET, BY TOOL, 2023–2030 (USD MILLION)            441

TABLE 488            CHINA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,

2023–2030 (USD MILLION)            442

TABLE 489            CHINA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,

2023–2030 (USD MILLION)            442

TABLE 490            CHINA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,

BY TYPE, 2023–2030 (USD MILLION)         443

TABLE 491            CHINA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,

BY TYPE, 2023–2030 (USD MILLION)         443

TABLE 492            CHINA: AI IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION)                444

TABLE 493            CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2023–2030 (USD MILLION)         444

TABLE 494            CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,

2023–2030 (USD MILLION)            445

TABLE 495            JAPAN: AI IN HEALTHCARE MARKET, BY OFFERING, 2023–2030 (USD MILLION)     446

TABLE 496            JAPAN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)   446

TABLE 497            JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,

BY TYPE, 2023–2030 (USD MILLION)         447

TABLE 498            JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            447

TABLE 499            JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,

2023–2030 (USD MILLION)            448

TABLE 500            JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY APPLICATION, 2023–2030 (USD MILLION)       448

TABLE 501            JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY MODALITY, 2023–2030 (USD MILLION)             449

TABLE 502            JAPAN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)       449

TABLE 503            JAPAN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION) 450

TABLE 504            JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         450

TABLE 505            JAPAN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,

2023–2030 (USD MILLION)            450

TABLE 506            JAPAN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,

2023–2030 (USD MILLION)            451

TABLE 507            JAPAN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION) 451

TABLE 508            JAPAN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,

2023–2030 (USD MILLION)            451

TABLE 509            JAPAN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)            452

TABLE 510            JAPAN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)            452

TABLE 511            JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,

BY TYPE, 2023–2030 (USD MILLION)         453

TABLE 512            JAPAN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,

BY TYPE, 2023–2030 (USD MILLION)         453

TABLE 513            JAPAN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              454

TABLE 514            JAPAN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            454

TABLE 515            JAPAN: AI IN HEALTHCARE MARKET, BY TOOL, 2023–2030 (USD MILLION)            454

TABLE 516            JAPAN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING,

BY TYPE, 2023–2030 (USD MILLION)         455

TABLE 517            JAPAN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,

2023–2030 (USD MILLION)            455

TABLE 518            JAPAN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,

BY TYPE, 2023–2030 (USD MILLION)         456

TABLE 519            JAPAN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023–2030 (USD MILLION)            456

TABLE 520            JAPAN: AI IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION)                457

TABLE 521            JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)                 457

TABLE 522            JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,

2023–2030 (USD MILLION)            458

TABLE 523            INDIA: AI IN HEALTHCARE MARKET, BY OFFERING, 2023–2030 (USD MILLION)     459

TABLE 524            INDIA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)   459

TABLE 525            INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023–2030 (USD MILLION)            460

TABLE 526            INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            460

TABLE 527            INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,

2023–2030 (USD MILLION)            461

TABLE 528            INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023–2030 (USD MILLION)            461

TABLE 529            INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023–2030 (USD MILLION)            462

TABLE 530            INDIA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)       462

TABLE 531            INDIA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION) 463

TABLE 532            INDIA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         463

TABLE 533            INDIA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,

2023–2030 (USD MILLION)            463

TABLE 534            INDIA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,

2023–2030 (USD MILLION)            464

TABLE 535            INDIA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION) 464

TABLE 536            INDIA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,

2023–2030 (USD MILLION)            464

TABLE 537            INDIA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)            465

TABLE 538            INDIA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)            465

TABLE 539            INDIA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,

BY TYPE, 2023–2030 (USD MILLION)         466

TABLE 540            INDIA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,

BY TYPE, 2023–2030 (USD MILLION)         466

TABLE 541            INDIA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              467

TABLE 542            INDIA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            467

TABLE 543            INDIA: AI IN HEALTHCARE MARKET, BY TOOL, 2023–2030 (USD MILLION)            467

TABLE 544            INDIA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,

2023–2030 (USD MILLION)            468

TABLE 545            INDIA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,

2023–2030 (USD MILLION)            468

TABLE 546            INDIA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,

BY TYPE, 2023–2030 (USD MILLION)         469

TABLE 547            INDIA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023–2030 (USD MILLION)            469

TABLE 548            INDIA: AI IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION)                469

TABLE 549            INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,

2023–2030 (USD MILLION)            470

TABLE 550            INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,

2023–2030 (USD MILLION)            470

TABLE 551            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING,

2023–2030 (USD MILLION)            471

TABLE 552            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            472

TABLE 553            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023–2030 (USD MILLION)       472

TABLE 554            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023–2030 (USD MILLION)                 473

TABLE 555            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023–2030 (USD MILLION)                 473

TABLE 556            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY APPLICATION, 2023–2030 (USD MILLION)       473

TABLE 557            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY MODALITY, 2023–2030 (USD MILLION)             474

TABLE 558            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)         474

TABLE 559            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION)                475

TABLE 560            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023–2030 (USD MILLION)       475

TABLE 561            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         475

TABLE 562            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         476

TABLE 563            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION)                476

TABLE 564            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY,

BY TYPE, 2023–2030 (USD MILLION)         476

TABLE 565            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)          477

TABLE 566            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)                 477

TABLE 567            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 478

TABLE 568            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023–2030 (USD MILLION)       478

TABLE 569            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            479

TABLE 570            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)                 479

TABLE 571            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL,

2023–2030 (USD MILLION)            479

TABLE 572            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING,

BY TYPE, 2023–2030 (USD MILLION)         480

TABLE 573            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING,

BY TYPE, 2023–2030 (USD MILLION)         480

TABLE 574            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023–2030 (USD MILLION)            481

TABLE 575            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023–2030 (USD MILLION)       481

TABLE 576            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            482

TABLE 577            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 482

TABLE 578            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2023–2030 (USD MILLION)         483

TABLE 579            LATIN AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            484

TABLE 580            LATIN AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING,

2023–2030 (USD MILLION)            485

TABLE 581            LATIN AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            485

TABLE 582            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023–2030 (USD MILLION)            486

TABLE 583            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            486

TABLE 584            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,

2023–2030 (USD MILLION)            487

TABLE 585            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY APPLICATION, 2023–2030 (USD MILLION)       487

TABLE 586            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY MODALITY, 2023–2030 (USD MILLION)             488

TABLE 587            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)            488

TABLE 588            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION)       489

TABLE 589            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023–2030 (USD MILLION)            489

TABLE 590            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         489

TABLE 591            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         490

TABLE 592            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION)            490

TABLE 593            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY,

BY TYPE, 2023–2030 (USD MILLION)         490

TABLE 594            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)                491

TABLE 595            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)         491

TABLE 596            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,

BY TYPE, 2023–2030 (USD MILLION)         492

TABLE 597            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,

BY TYPE, 2023–2030 (USD MILLION)         492

TABLE 598            LATIN AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            493

TABLE 599            LATIN AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            493

TABLE 600            LATIN AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2023–2030 (USD MILLION)       493

TABLE 601            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING,

BY TYPE, 2023–2030 (USD MILLION)         494

TABLE 602            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING,

BY TYPE, 2023–2030 (USD MILLION)         494

TABLE 603            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 495

TABLE 604            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023–2030 (USD MILLION)            495

TABLE 605            LATIN AMERICA: AI IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            495

TABLE 606            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2023–2030 (USD MILLION)         496

TABLE 607            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2023–2030 (USD MILLION)         496

TABLE 608            BRAZIL: AI IN HEALTHCARE MARKET, BY OFFERING, 2023–2030 (USD MILLION)     497

TABLE 609            BRAZIL: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)   498

TABLE 610            BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,

BY TYPE, 2023–2030 (USD MILLION)         498

TABLE 611            BRAZIL: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            499

TABLE 612            BRAZIL: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,

2023–2030 (USD MILLION)            499

TABLE 613            BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY APPLICATION, 2023–2030 (USD MILLION)       499

TABLE 614            BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY MODALITY, 2023–2030 (USD MILLION)             500

TABLE 615            BRAZIL: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)       500

TABLE 616            BRAZIL: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION) 501

TABLE 617            BRAZIL: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         501

TABLE 618            BRAZIL: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,

2023–2030 (USD MILLION)            501

TABLE 619            BRAZIL: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,

2023–2030 (USD MILLION)            502

TABLE 620            BRAZIL: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION) 502

TABLE 621            BRAZIL: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,

2023–2030 (USD MILLION)            502

TABLE 622            BRAZIL: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)            503

TABLE 623            BRAZIL: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)                503

TABLE 624            BRAZIL: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,

BY TYPE, 2023–2030 (USD MILLION)         504

TABLE 625            BRAZIL: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,

BY TYPE, 2023–2030 (USD MILLION)         504

TABLE 626            BRAZIL: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              505

TABLE 627            BRAZIL: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            505

TABLE 628            BRAZIL: AI IN HEALTHCARE MARKET, BY TOOL, 2023–2030 (USD MILLION)            505

TABLE 629            BRAZIL: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,

2023–2030 (USD MILLION)            506

TABLE 630            BRAZIL: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,

2023–2030 (USD MILLION)            506

TABLE 631            BRAZIL: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,

BY TYPE, 2023–2030 (USD MILLION)         507

TABLE 632            BRAZIL: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,

BY TYPE, 2023–2030 (USD MILLION)         507

TABLE 633            BRAZIL: AI IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION)                507

TABLE 634            BRAZIL: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)                 508

TABLE 635            BRAZIL: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,

2023–2030 (USD MILLION)            508

TABLE 636            MEXICO: AI IN HEALTHCARE MARKET, BY OFFERING, 2023–2030 (USD MILLION)     509

TABLE 637            MEXICO: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)   509

TABLE 638            MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,

BY TYPE, 2023–2030 (USD MILLION)         510

TABLE 639            MEXICO: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            510

TABLE 640            MEXICO: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,

2023–2030 (USD MILLION)            511

TABLE 641            MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY APPLICATION, 2023–2030 (USD MILLION)       511

TABLE 642            MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY MODALITY, 2023–2030 (USD MILLION)             512

TABLE 643            MEXICO: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)       512

TABLE 644            MEXICO: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION) 513

TABLE 645            MEXICO: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         513

TABLE 646            MEXICO: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,

2023–2030 (USD MILLION)            513

TABLE 647            MEXICO: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,

2023–2030 (USD MILLION)            514

TABLE 648            MEXICO: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION) 514

TABLE 649            MEXICO: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,

2023–2030 (USD MILLION)            514

TABLE 650            MEXICO: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)            515

TABLE 651            MEXICO: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)                515

TABLE 652            MEXICO: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,

BY TYPE, 2023–2030 (USD MILLION)         516

TABLE 653            MEXICO: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,

BY TYPE, 2023–2030 (USD MILLION)         516

TABLE 654            MEXICO: AI IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            517

TABLE 655            MEXICO: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            517

TABLE 656          MEXICO: AI IN HEALTHCARE MARKET, BY TOOL, 2023–2030 (USD MILLION)            517

TABLE 657            MEXICO: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,

2023–2030 (USD MILLION)            518

TABLE 658            MEXICO: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,

2023–2030 (USD MILLION)            518

TABLE 659            MEXICO: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,

BY TYPE, 2023–2030 (USD MILLION)         519

TABLE 660            MEXICO: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,

BY TYPE, 2023–2030 (USD MILLION)         519

TABLE 661            MEXICO: AI IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION)                519

TABLE 662            MEXICO: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2023–2030 (USD MILLION)         520

TABLE 663            MEXICO: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2023–2030 (USD MILLION)         520

TABLE 664            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING,

2023–2030 (USD MILLION)            521

TABLE 665            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            522

TABLE 666            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023–2030 (USD MILLION)       522

TABLE 667            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023–2030 (USD MILLION)                 523

TABLE 668            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023–2030 (USD MILLION)                 523

TABLE 669            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023–2030 (USD MILLION)       523

TABLE 670            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023–2030 (USD MILLION) 524

TABLE 671            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)         524

TABLE 672            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION)                525

TABLE 673            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023–2030 (USD MILLION)       525

TABLE 674            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         525

TABLE 675            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023–2030 (USD MILLION)            526

TABLE 676            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION)                526

TABLE 677            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY,

BY TYPE, 2023–2030 (USD MILLION)         526

TABLE 678            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)          527

TABLE 679            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)                 527

TABLE 680            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 528

TABLE 681            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023–2030 (USD MILLION)       528

TABLE 682            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            529

TABLE 683            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)                 529

TABLE 684            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY TOOL,

2023–2030 (USD MILLION)            529

TABLE 685            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023–2030 (USD MILLION)            530

TABLE 686            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING,

BY TYPE, 2023–2030 (USD MILLION)         530

TABLE 687            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023–2030 (USD MILLION)            531

TABLE 688            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023–2030 (USD MILLION)       531

TABLE 689            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            532

TABLE 690            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 532

TABLE 691            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION)            533

TABLE 692            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY REGION,

2023–2030 (USD MILLION)            535

TABLE 693            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING,

2023–2030 (USD MILLION)            535

TABLE 694            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            536

TABLE 695            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023–2030 (USD MILLION)       536

TABLE 696            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023–2030 (USD MILLION)                 537

TABLE 697            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023–2030 (USD MILLION)                 537

TABLE 698            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023–2030 (USD MILLION)       537

TABLE 699            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023–2030 (USD MILLION) 538

TABLE 700            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)         538

TABLE 701            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION)                539

TABLE 702            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023–2030 (USD MILLION)       539

TABLE 703            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         539

TABLE 704            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         540

TABLE 705            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION)                540

TABLE 706            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY,

BY TYPE, 2023–2030 (USD MILLION)         540

TABLE 707            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)          541

TABLE 708            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)                 541

TABLE 709            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 542

TABLE 710            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023–2030 (USD MILLION)       542

TABLE 711            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            543

TABLE 712            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)                 543

TABLE 713            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY TOOL,

2023–2030 (USD MILLION)            543

TABLE 714            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING,

BY TYPE, 2023–2030 (USD MILLION)         544

TABLE 715            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING,

BY TYPE, 2023–2030 (USD MILLION)         544

TABLE 716            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023–2030 (USD MILLION)            545

TABLE 717            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023–2030 (USD MILLION)       545

TABLE 718            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            546

TABLE 719            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 546

TABLE 720            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION)            547

TABLE 721            GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY OFFERING,

2023–2030 (USD MILLION)            548

TABLE 722            GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            548

TABLE 723            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023–2030 (USD MILLION)            549

TABLE 724            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,

2023–2030 (USD MILLION)            549

TABLE 725            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,

2023–2030 (USD MILLION)            550

TABLE 726            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY APPLICATION, 2023–2030 (USD MILLION)       550

TABLE 727            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,

BY MODALITY, 2023–2030 (USD MILLION)             551

TABLE 728            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023–2030 (USD MILLION)            551

TABLE 729            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION)       552

TABLE 730            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023–2030 (USD MILLION)            552

TABLE 731            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         553

TABLE 732            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY,

BY TYPE, 2023–2030 (USD MILLION)         553

TABLE 733            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION)            554

TABLE 734            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY,

BY TYPE, 2023–2030 (USD MILLION)         554

TABLE 735            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)                555

TABLE 736            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023–2030 (USD MILLION)         555

TABLE 737            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,

BY TYPE, 2023–2030 (USD MILLION)         556

TABLE 738            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023–2030 (USD MILLION)            556

TABLE 739            GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            557

TABLE 740            GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2023–2030 (USD MILLION)            557

TABLE 741            GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY TOOL,

2023–2030 (USD MILLION)            557

TABLE 742            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING,

BY TYPE, 2023–2030 (USD MILLION)         558

TABLE 743            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DEEP LEARNING,

BY TYPE, 2023–2030 (USD MILLION)         558

TABLE 744            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 559

TABLE 745            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023–2030 (USD MILLION)            559

TABLE 746            GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            559

TABLE 747            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2023–2030 (USD MILLION)         560

TABLE 748            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS,

BY TYPE, 2023–2030 (USD MILLION)         560

TABLE 749            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2023–2030 (USD MILLION)            561

TABLE 750            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET,

BY FUNCTION, 2023–2030 (USD MILLION)             562

TABLE 751            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023–2030 (USD MILLION)         562

TABLE 752            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     563

TABLE 753            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD,

BY APPLICATION, 2023–2030 (USD MILLION)       563

TABLE 754            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023–2030 (USD MILLION)              563

TABLE 755            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023–2030 (USD MILLION)   564

TABLE 756            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE,

2023–2030 (USD MILLION)            564

TABLE 757            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023–2030 (USD MILLION) 565

TABLE 758            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023–2030 (USD MILLION)                565

TABLE 759            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023–2030 (USD MILLION)            565

TABLE 760            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023–2030 (USD MILLION)            566

TABLE 761            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023–2030 (USD MILLION)  566

TABLE 762            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023–2030 (USD MILLION)       566

TABLE 763            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023–2030 (USD MILLION)                 567

TABLE 764            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE,

2023–2030 (USD MILLION)            567

TABLE 765            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)                568

TABLE 766            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023–2030 (USD MILLION)                568

TABLE 767            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       569

TABLE 768            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET,

BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)     569

TABLE 769            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET,

BY TOOL, 2023–2030 (USD MILLION)       569

TABLE 770            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2023–2030 (USD MILLION)            570

TABLE 771            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2023–2030 (USD MILLION)       570

TABLE 772            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023–2030 (USD MILLION)            571

TABLE 773            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023–2030 (USD MILLION)                571

TABLE 774            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION)            572

TABLE 775            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)                572

TABLE 776            REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION)            573

TABLE 777            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET, JANUARY 2021–APRIL 2025        575

TABLE 778            AI IN HEALTHCARE MARKET SHARE ANALYSIS, 2024        580

TABLE 779            AI IN HEALTHCARE MARKET: REGIONAL FOOTPRINT, 2024             586

TABLE 780            AI IN HEALTHCARE MARKET: APPLICATION FOOTPRINT, 2024             587

TABLE 781            AI IN HEALTHCARE MARKET: TOOL FOOTPRINT, 2024             588

TABLE 782            AI IN HEALTHCARE MARKET: FUNCTION FOOTPRINT, 2024             589

TABLE 783            AI IN HEALTHCARE MARKET: OFFERING FOOTPRINT, 2024             590

TABLE 784            AI IN HEALTHCARE MARKET: DEPLOYMENT FOOTPRINT, 2024             591

TABLE 785            AI IN HEALTHCARE MARKET: END-USER FOOTPRINT, 2024             592

TABLE 786            AI IN HEALTHCARE MARKET: DETAILED LIST OF KEY STARTUP/

SME PLAYERS, 2024          595

TABLE 787            AI IN HEALTHCARE MARKET: APPLICATION AND REGIONAL FOOTPRINT (STARTUPS/SMES), 2024    596

TABLE 788            AI IN HEALTHCARE MARKET: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025   599

TABLE 789            AI IN HEALTHCARE MARKET: DEALS, JANUARY 2021–APRIL 2025                600

TABLE 790            AI IN HEALTHCARE MARKET: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2025       601

TABLE 791            KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW          603

TABLE 792            KONINKLIJKE PHILIPS N.V.: PRODUCTS & SERVICES OFFERED        604

TABLE 793            KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES          607

TABLE 794            KONINKLIJKE PHILIPS N.V.: DEALS          608

TABLE 795            KONINKLIJKE PHILIPS N.V.: EXPANSIONS                 610

TABLE 796            KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS              611

TABLE 797            MICROSOFT CORPORATION: COMPANY OVERVIEW          613

TABLE 798            MICROSOFT CORPORATION: PRODUCTS & SERVICES OFFERED        615

TABLE 799            MICROSOFT CORPORATION: PRODUCT LAUNCHES          616

TABLE 800            MICROSOFT CORPORATION: DEALS      617

TABLE 801            NVIDIA CORPORATION: COMPANY OVERVIEW                 620

TABLE 802            NVIDIA CORPORATION: PRODUCTS & SERVICES OFFERED             621

TABLE 803            NVIDIA CORPORATION: PRODUCT LAUNCHES                 622

TABLE 804            NVIDIA CORPORATION: DEALS 623

TABLE 805            SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW          625

TABLE 806            SIEMENS HEALTHINEERS AG: PRODUCTS & SERVICES OFFERED        627

TABLE 807            SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & ENHANCEMENTS 628

TABLE 808            SIEMENS HEALTHINEERS AG: DEALS      628

TABLE 809            SIEMENS HEALTHINEERS AG: OTHER DEVELOPMENTS              630

TABLE 810            GE HEALTHCARE: COMPANY OVERVIEW                 632

TABLE 811            GE HEALTHCARE: PRODUCTS & SERVICES OFFERED             634

TABLE 812            GE HEALTHCARE: DEALS             635

TABLE 813            GE HEALTHCARE: OTHER DEVELOPMENTS                 636

TABLE 814            EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW          638

TABLE 815            EPIC SYSTEMS CORPORATION: PRODUCTS & SERVICES OFFERED        638

TABLE 816            EPIC SYSTEMS CORPORATION: DEALS  639

TABLE 817            ORACLE CORPORATION: COMPANY OVERVIEW                 640

TABLE 818            ORACLE: PRODUCTS & SERVICES OFFERED                 641

TABLE 819            ORACLE: PRODUCT LAUNCHES                 642

TABLE 820            ORACLE CORPORATION: DEALS               643

TABLE 821            ORACLE: EXPANSIONS  644

TABLE 822            VERADIGM LLC: COMPANY OVERVIEW 645

TABLE 823            VERADIGM LLC: PRODUCTS & SERVICES OFFERED             646

TABLE 824            VERADIGM LLC: DEALS 647

TABLE 825            AMAZON WEB SERVICES, INC.: COMPANY OVERVIEW          648

TABLE 826            AMAZON WEB SERVICES, INC.: PRODUCTS & SERVICES OFFERED        649

TABLE 827            AMAZON WEB SERVICES, INC.: PRODUCT LAUNCHES          650

TABLE 828            AMAZON WEB SERVICES, INC.: DEALS    651

TABLE 829            AMAZON WEB SERVICES, INC.: EXPANSIONS                 652

TABLE 830            MERATIVE: COMPANY OVERVIEW           653

TABLE 831            MERATIVE: PRODUCTS & SERVICES OFFERED                 653

TABLE 832            MERATIVE: PRODUCT LAUNCHES            654

TABLE 833            MERATIVE: DEALS           654

TABLE 834            IBM: COMPANY OVERVIEW         655

TABLE 835            IBM: PRODUCTS & SERVICES OFFERED 656

TABLE 836            IBM: DEALS        657

TABLE 837            MEDTRONIC: COMPANY OVERVIEW       658

TABLE 838            MEDTRONIC: PRODUCTS & SERVICES OFFERED                 659

TABLE 839            MEDTRONIC: PRODUCT LAUNCHES       660

TABLE 840            MEDTRONIC: DEALS      661

TABLE 841            GOOGLE: COMPANY OVERVIEW               662

TABLE 842            GOOGLE: PRODUCTS & SERVICES OFFERED                 663

TABLE 843            GOOGLE: PRODUCT LAUNCHES               664

TABLE 844            GOOGLE: DEALS              665

TABLE 845            GOOGLE: OTHER DEVELOPMENTS         667

TABLE 846            SOPHIA GENETICS: COMPANY OVERVIEW                 668

TABLE 847            SOPHIA GENETICS: PRODUCTS & SERVICES OFFERED             669

TABLE 848            SOPHIA GENETICS: PRODUCT LAUNCHES                 669

TABLE 849            SOPHIA GENETICS: DEALS           670

TABLE 850            SOPHIA GENETICS: OTHER DEVELOPMENTS                 671

TABLE 851            JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW   672

TABLE 852            JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS & SERVICES OFFERED            673

TABLE 853            JOHNSON & JOHNSON SERVICES, INC.: OTHER DEVELOPMENTS              674

TABLE 854            JOHNSON & JOHNSON SERVICES, INC.: DEALS                 674

TABLE 855            TEMPUS AI, INC. COMPANY OVERVIEW 675

TABLE 856            TEMPUS AI, INC. PRODUCTS & SERVICES OFFERED             676

TABLE 857            TEMPUS AI, INC.: PRODUCT LAUNCHES                 677

TABLE 858            TEMPUS AI, INC. DEALS                 678

TABLE 859            CONCERTAI: COMPANY OVERVIEW        679

TABLE 860            CONCERTAI: PRODUCTS & SERVICES OFFERED                 679

TABLE 861            CONCERTAI: PRODUCT LAUNCHES        680

TABLE 862            CONCERTAI: DEALS        681

TABLE 863            SOLVENTUM CORPORATION: COMPANY OVERVIEW          683

TABLE 864            SOLVENTUM CORPORATION: PRODUCTS & SERVICES OFFERED        684

TABLE 865            SOLVENTUM CORPORATION: DEALS     685

TABLE 866            SOLVENTUM CORPORATION: OTHER DEVELOPMENTS              685

TABLE 867            COGNIZANT: COMPANY OVERVIEW       686

TABLE 868            COGNIZANT: PRODUCTS & SERVICES OFFERED                 688

TABLE 869            COGNIZANT: PRODUCT LAUNCHES       688

TABLE 870            COGNIZANT: DEALS       689

TABLE 871            VIZ.AI, INC.: COMPANY OVERVIEW          690

TABLE 872            VIZ.AI, INC.: PRODUCTS & SERVICES OFFERED                 690

TABLE 873            VIZ.AI, INC.: PRODUCT LAUNCHES          691

TABLE 874            VIZ.AI, INC.: DEALS         692

TABLE 875            VIZ.AI, INC.: OTHER DEVELOPMENTS    694

TABLE 876            RIVERAIN TECHNOLOGIES: COMPANY OVERVIEW          695

TABLE 877            RIVERAIN TECHNOLOGIES: PRODUCTS & SERVICES OFFERED        695

TABLE 878            RIVERAIN TECHNOLOGIES: DEALS          696

LIST OF FIGURES

FIGURE 1              AI IN HEALTHCARE MARKET SEGMENTATION & REGIONAL SCOPE            59

FIGURE 2              YEARS CONSIDERED      63

FIGURE 3              RESEARCH DESIGN         65

FIGURE 4              KEY DATA FROM SECONDARY SOURCES                 67

FIGURE 5              PRIMARY SOURCES         68

FIGURE 6              KEY INSIGHTS FROM INDUSTRY EXPERTS                 69

FIGURE 7              BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE), BY COMPANY TYPE, DESIGNATION, AND REGION                69

FIGURE 8              MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS            70

FIGURE 9              BOTTOM-UP APPROACH: END-USER SPENDING ON AI IN HEALTHCARE 71

FIGURE 10            AI IN HEALTHCARE MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES, 2025–2030                 73

FIGURE 11            CAGR PROJECTION: SUPPLY-SIDE ANALYSIS                 74

FIGURE 12            TOP-DOWN APPROACH                74

FIGURE 13            DATA TRIANGULATION METHODOLOGY                 76

FIGURE 14            AI IN HEALTHCARE MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)      79

FIGURE 15            AI IN HEALTHCARE MARKET, BY FUNCTION, 2025 VS. 2030 (USD MILLION)      80

FIGURE 16            AI IN HEALTHCARE MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)      81

FIGURE 17            AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2025 VS. 2030 (USD MILLION)      81

FIGURE 18            AI IN HEALTHCARE MARKET, BY TOOL, 2025 VS. 2030 (USD MILLION)       82

FIGURE 19            AI IN HEALTHCARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)                83

FIGURE 20            AI IN HEALTHCARE MARKET: REGIONS COVERED            84

FIGURE 21            RISING NEED FOR EARLY DISEASE DETECTION TO DRIVE MARKET         85

FIGURE 22            INTEGRATED SOLUTIONS AND JAPAN LED RESPECTIVE SEGMENTS

IN ASIA PACIFIC IN 2024                 86

FIGURE 23            INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD       87

FIGURE 24            NORTH AMERICA TO DOMINATE AI IN HEALTHCARE MARKET DURING FORECAST PERIOD      87

FIGURE 25            EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD    88

FIGURE 26            AI IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES         89

FIGURE 27            DATA BREACHES IN HEALTHCARE SECTOR, 2019–2023              99

FIGURE 28            CHALLENGES ASSOCIATED WITH HEALTHCARE DATA INTEROPERABILITY          100

FIGURE 29            TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES           100

FIGURE 30            AI IN HEALTHCARE MARKET: VALUE CHAIN ANALYSIS            106

FIGURE 31            AI IN HEALTHCARE MARKET: ECOSYSTEM MAPPING             108

FIGURE 32            GLOBAL PATENT PUBLICATION TRENDS IN AI IN HEALTHCARE

MARKET, 2017–2024          110

FIGURE 33            TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR AI IN HEALTHCARE PATENTS, JANUARY 2017–DECEMBER 2024            111

FIGURE 34            TOP APPLICANTS FOR AI IN HEALTHCARE PATENTS (COUNTRY/REGION),

JANUARY 2017–DECEMBER 2024 112

FIGURE 35            AI IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS           125

FIGURE 36            INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP

THREE END USERS          127

FIGURE 37            KEY BUYING CRITERIA FOR TOP THREE END USERS   128

FIGURE 38            AI IN HEALTHCARE MARKET: INVESTMENT & FUNDING SCENARIO,

2024 (USD MILLION)       132

FIGURE 39            GEN AI USE CASES IN HEALTHCARE        134

FIGURE 40            INTERCONNECTED AND ADJACENT ECOSYSTEMS    136

FIGURE 41            NORTH AMERICA: AI IN HEALTHCARE MARKET SNAPSHOT          278

FIGURE 42            ASIA PACIFIC: AI IN HEALTHCARE MARKET SNAPSHOT          417

FIGURE 43            REVENUE ANALYSIS OF KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2020–2024            578

FIGURE 44            MARKET SHARE ANALYSIS OF KEY PLAYERS IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2024                 579

FIGURE 45            RANKING OF KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2024      582

FIGURE 46            AI IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024         584

FIGURE 47            AI IN HEALTHCARE MARKET: COMPANY FOOTPRINT, 2024             585

FIGURE 48            AI IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX

(STARTUPS/SMES), 2024                594

FIGURE 49            EV/EBITDA OF KEY VENDORS, 2025         596

FIGURE 50            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025            597

FIGURE 51            AI IN HEALTHCARE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS     598

FIGURE 52            KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024)             604

FIGURE 53            MICROSOFT CORPORATION: COMPANY SNAPSHOT (2024)             614

FIGURE 54            NVIDIA CORPORATION: COMPANY SNAPSHOT (2024)    621

FIGURE 55            SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024)             626

FIGURE 56            GE HEALTHCARE: COMPANY SNAPSHOT (2024)                 633

FIGURE 57            ORACLE CORPORATION: COMPANY SNAPSHOT (2024)    641

FIGURE 58            VERADIGM INC.: COMPANY SNAPSHOT (2022)                 646

FIGURE 59            AMAZON WEB SERVICES, INC.: COMPANY SNAPSHOT (2024)             649

FIGURE 60            IBM: COMPANY SNAPSHOT (2024)            656

FIGURE 61            MEDTRONIC: COMPANY SNAPSHOT (2024)                 659

FIGURE 62            GOOGLE: COMPANY SNAPSHOT (2024) 663

FIGURE 63            SOPHIA GENETICS: COMPANY SNAPSHOT (2024)    668

FIGURE 64            JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2024)      673

FIGURE 65            TEMPUS: COMPANY SNAPSHOT (2024)  676

FIGURE 66            SOLVENTUM CORPORATION: COMPANY SNAPSHOT (2024)             684

FIGURE 67            COGNIZANT: COMPANY SNAPSHOT (2024)                 687